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Signature-tagged mutagenesis: technical advances in a negative
selection method for virulence gene identification
Henri L Saenz and Christoph DehioSignature-tagged mutagenesis (STM) is a powerful negative
selection method, predominantly used to identify the genes of a
pathogen that are required for the successful colonization of an
animal host. Since its first description a decade ago, STM has
been applied to screen a vast amount of transposon insertion
mutants in 31 bacterial species. This has led to the
identification of over 1700 bacterial genes that are involved in
virulence. Despite the preservation of the basic design, the
STM method has been developed further owing to recent
advances including different designs of the signature-tags and
profound changes in the mode of detection. These advances
promoted substantially the application range and versatility of
the STM method.Addresses
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Introduction
The availability of complete genome sequences for most
bacterial pathogens increased substantially the number of
genes with unknown function. Genome-wide approaches
to functionally characterize these genes in the process of
infection have become of great importance. Gene-disrup-
tion strategies, such as random transposon mutagenesis,
produce insertion mutants that can be tested for attenu-
ated virulence (e.g. in an animal infection model). The
isolation of attenuated mutants thus leads to the identi-
fication of genes or operons that are required for survival
in the infected host. Before the invention of signature-
tagged mutagenesis (STM) ten years ago by David Hol-
den and co-workers [1], these mutants had to be screened
one by one; however, STM combines the power of
insertional mutagenesis and negative selection with a
detection system, which allows one to identify individual
attenuated mutants from a complex mutant pool
(Figure 1). To this end, STM uses signature-tags (i.e.COMICR 293
www.sciencedirect.comshort individual DNA sequences) inserted in the trans-
posons to mark mutants individually. Mutants that carry
distinct signature-tags are pooled and injected into the
animal host to test in parallel for their survival. This is
advantageous as it minimizes both the work-load and the
number of animals required.
Owing to its frequent application, STM has been
reviewed extensively in recent years [2–7]. Review arti-
cles have compared technical variations in STM studies
[5], have presented limitations of the STM approach
[2,3], and have summarized the results of STM studies
until 2000 [4] and 2001 [6]. In this review, we highlight
the modular structure of this powerful negative selection
method and focus on the technical advances since 2002.
Modular structure of the signature-tagged
mutagenesis approach
For the purpose of this review, we present STM as a
flowchart of interconnected modules, as depicted in
Figure 2. The original STM approach described by
Hensel et al. [1] was designed to detect new virulence
genes of the target organism Salmonella typhimurium in a
murine model of typhoid fever. To this end, miniTn5
transposons that contained signature-tags composed of
random sequences of 40 bp were randomly inserted into
the bacterial genome, yielding a tagged mutant library.
To validate the suitability of individual tags for detection
within a pool of differently tagged mutants, single
mutants were pooled and used for test hybridizations.
Therefore, the tags of a pool were polymerase chain
reaction (PCR)-amplified with universal tag primers,
radioactively labeled, and hybridized on membranes
spotted with DNA from the corresponding mutants. Only
mutants with clear tag hybridization signals were
included in the subsequent selection process. Input pools
of 96 mutants were subjected to a negative selection
system, in this case a mouse infection model. The corre-
sponding output pools recovered after selection were
grown on complex medium and their tags amplified
and labeled for detection. A weak or absent hybridization
signal from the output pool compared to the input pool
identified attenuated mutants (Figure 3a). These mutants
were tested by different means (e.g. for competition with
wild-type bacteria in mixed infections) to validate the
screening results. Identification of the mutation site by
cloning and sequencing revealed known virulence genes,
but also genes previously unrelated to virulence and those
with unknown function. Most strikingly, further charac-
terization of selected mutants led to the discovery of a
novel Salmonella pathogenicity island (SPI-2) [8].Current Opinion in Microbiology 2005, 8:1–8
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Figure 1
Comparison of standard random transposon mutagenesis (RTM) and signature-tagged mutagenesis (STM), displaying similarities and differences
between these two methods.Since this initial STM study, numerous STM screens
have followed a similar protocol. Modifications within
individual modules have increased the versatility of the
STM method. Some target organisms, such as Neisseria
meningitidis, are refractory to transposon mutagenesis,
leading Sun et al. [9] to use in vitro mutagenesis and
homologous recombination to assemble the tagged
mutant library. Other STM studies have used two dif-
ferent negative selection systems [10] or have re-screened
to validate their initial screen results by constructing new
pools with attenuated mutants and submitting them to a
second screen under the same or similar conditions as in
the initial screen [11]. In addition, profound changes have
been made to some of the modules of the STM screen.
For tag validation, Mei et al. [12] introduced pre-selection
of tags that showed reproducible detection and no cross-
reactivity. Each tagged transposon could be subsequently
used separately to generate a large amount of tagged
mutants. Many STM studies adopted this procedure or
directly used the pre-selected tags from previous studies,
facilitating the establishment of the method for the
specific needs of the study. Also, the way in which
mutants are detected has changed profoundly from the
original STM methodology. Lehoux et al. [13] introduced
PCR detection instead of hybridization (Figure 3b).
Recent advances in signature-tagged
mutagenesis
In recent years, many new STM studies have been
carried out (Table 1). We summarize the major technicalCurrent Opinion in Microbiology 2005, 8:1–8changes in the different modules of these STM studies
(Table 2).
Target organism
Although most STM studies examine pathogen–host
interactions, the method is not limited to this application.
One recent study investigated the symbiont–host inter-
action for Xenorhabdus nematophila in its nematode host
Steinernema carpocapsae [14] and another studied the
commensal–host interaction for Campylobacter jejuni in
chicken [15].
Transposon
Most studies to date have applied the miniTn5 transpo-
son system [16], which was used in the original STM
screen [1] for tag-delivery and mutation of the chosen
target organism. This system works in g-Proteobacteria,
among others, but as host factors are required for trans-
position and owing to target DNA composition, some
bacteria are (nearly) refractory to random mutagenesis by
Tn5-derived transposons. For this reason, several recent
studies in Streptococcus pneumoniae, N. meningitidis and C.
jejuni [15,17,18] applied transposons from the mariner
family, such as magellan2 or Himar1 [19]. The activity of
these transposons is not dependent on host factors and
thus they are applicable to a broad variety of organisms,
and only the respective transposase is needed for in vitro
transposition [20]. The high frequency of transposition
and the low insertion-site specificity render these trans-
posons ideal for random transposon mutagenesis [21].www.sciencedirect.com
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Figure 2
Flowchart overview of the different modules and their interconnectivity
in an STM screen. The core components of the STM method are shown in
grey/green boxes and the optional components are presented in white
boxes. The modules are discussed in more detail in the main text.Tags
The original STM approach applied signature tags with
40 bp random sequence for hybridization-detection. To
allow hybridization-detection on a high-density oligonu-
cleotide array chip, Karlyshev et al. [22] used double-tags
that had two variable regions of 20 bp (see module ‘detec-
tion system’). Lehoux et al. [13] pioneered detection by
PCR, presenting a totally new tag design in their STM
study of Pseudomonas aeruginosa lung infection [23]. The
tags used contained 13 bp of invariant region and a stretchwww.sciencedirect.comof 7 bp that is variable. By use of tag-specific PCR primers
together with a flanking generic primer, every tagged
mutant can be detected with a specific PCR reaction.
The common features of tags that are optimized for
hybridization or PCR are their constant size and their
variable sequence, which are required to discriminate
different tags. In size-marker tags, the variable size
enables tag discrimination, whereas their sequence is
not relevant. Walsh and Cepko [24] first used size-marker
tags, but in a totally different context. Two studies on
group A Streptococcus and Staphylococcus aureus adapted
this tag design for STM [25,26]. To construct size-
marker tags, Benton et al. [26] cloned 100–600 bp frag-
ments of unrelated DNA in a mutagenesis vector. As
these studies used different tag design and an alternative
mode of detection, they called their techniques poly-
morphic-tag-lengths-transposon-mutagenesis [25] and
size-marker identification technology [26]. Neverthe-
less, these techniques represent variations of STM.
Tagged mutant library
Benton et al. [26] employed pre-tagging of the target
organism before mutagenesis. Therefore, they integrated
the size-marker tags by site-directed mutagenesis in the
S. aureus genome without impairing virulence [26].
Thus, the random mutagenesis is independent from
the tagging step. The tag-insertion site must be chosen
carefully and even extensive testing does not exclude a
changed in vivo behavior of the target organism.
In all STM studies, a library of tagged mutants is
assembled. During this assembly, bacteria are cultivated
on plates or in liquid medium. Therefore, mutants with
transposon insertions in essential genes for growth are
excluded. By choosing defined culture conditions, specific
mutants can additionally be excluded, for example auxo-
trophic mutants by the use of minimal medium [27,28].
Not associated with virulence per se, specific auxotrophies
indicate the nutritional abundance or limitation inside
different host niches. However, this exclusion procedure
enables exact tailoring of the desired mutant library.
Negative selection system(s)
The negative selection system is the central module in
the STM technique. In vivo systems have a high selection
pressure and are, therefore, the screening system of
choice. This is reflected by their broad application in
STM studies. Additionally, the use of genetically mod-
ified (e.g. knockout or transgenic) animals extends the
versatility, as shown in the study of the counter-immune
strategy of Mycobacterium tuberculosis in immunodeficient
mice [29]. In the absence of an adequate in vivo system, in
vitro cell culture systems can represent an alternative.
However, in vitro results do not necessarily mirror in vivo
behavior; for example, a comparison of Klebsiella pneumo-
niae mutants obtained by in vivo (mice) and in vitroCurrent Opinion in Microbiology 2005, 8:1–8
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Figure 3
Comparison of two signature-tag detection methods in STM. (a) The original STM method, as developed by Hensel et al. [1], in which mutants
were detected by hybridization. From the mutant library, duplicate hybridization membranes are prepared (colony blots, dot blots with PCR
product or dot blots with plasmid DNA). Differently tagged mutants are pooled and an aliquot is used for the preparation of the input pool (IP)
hybridization probe. The mutant pool is subjected to the negative selection screening system (e.g. an animal model of infection) and mutants that
survive this screen are recovered for preparation of the output pool (OP) hybridization probe. PCR amplification and labeling yields the input and
output pool probes used to hybridize on the previously prepared membranes. The output and the input pool membranes are then compared.
Mutants that fail to be recovered from the negative selection screen produce a signal on the input pool membrane, but not on the output pool
membrane. (b) STM with PCR detection, as developed by Lehoux et al. [13]. After pooling of differently tagged mutants from the mutant library,
an aliquot from the input pool is used for detection of the individual tags by amplification with tag-specific primers. For each tag, one PCR
reaction is prepared. The mutant pool is subjected to the negative selection screening system and mutants that survive this screen are recovered
for detection of the individual tags of the output pool by amplification with tag-specific primers. Mutants that fail to be recovered from the
negative selection screen are identified as producing a PCR product with the input pool as template, but not with the output pool as template.(intestine cells) selection revealed a minimal overlap of
only one gene required in both conditions [30]. STM can
also be applied in the absence of an animal or cell culture
model as the only requirement is a negative selection
system. Geoffroy et al. [18] tested N. meningitidis for
factors required for serum resistance in a cell-free system.
Detection system
As outlined previously (Figure 3), hybridization and PCR
are two different detection methods. A special type of
detection by hybridization is the high-density oligonu-
cleotide array technique, in which the presence or
absence of 192 individual tag sequences that correspond
to 96 double-tags can be detected separately [22]. When
an STM study includes several negative selection
screens, the multi-screening approach of Struve et al.
[31] reduces work-load. This study describes a reversion
of a dot blot hybridization protocol by spotting the ampli-Current Opinion in Microbiology 2005, 8:1–8fied tags from the output pool on a membrane and then
probing this with an amplified and labeled probe that
contains all tags used for pool generation. The advantage
of this change is that the number of hybridizations neces-
sary to screen the mutant library in more than one screen-
ing system is substantially reduced because pools of tags
recovered from more than one screening system can be
analyzed simultaneously [31].
Many recent STM studies have used PCR detection,
which was established by Lehoux et al. [13] and then
applied in their recent P. aeruginosa-STM study [23]. The
basic principles of this method are depicted in Figure 3b.
The tags are amplified individually with a tag-specific
primer and a generic primer in a constant region flanking
the tag. The presence of a PCR product of one tag in the
input pool and absence of a PCR product for the same tag
in the output pool shows the loss of the specific taggedwww.sciencedirect.com
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Table 1
STM studies in bacteria (2002 to present).
Speciesa Route of
infectionb
Host Nichec Mutants (attenuated
versus screened)
Pool
size
Reference
Numbers %
S. e. Typhimurium ip Mice Spleen 40/1152 3.5 96 [1]
S. e. Typhimurium Oral Calves, chicken GI tract 84/1045 8.0 95 [35]
S. e. Choleraesuis Oral, ip Swine GI tract, spleen 3/45 6.7 45 [36]
Escherichia coli (UPEC) tu Mice Urinary tract 19/2049 0.9 46 [37]
E. coli (EHEC) Oral Calves GI tract 79/1900 4.2 95 [27]
E. coli (EHEC) Oral Calves GI tract 62/570 10.9 95 [38]
E. coli (APEC) it Chicken Spleen 30/1800 1.7 90 [39]
Vibrio cholerae Oral Mice Small intestine 251/9600 2.6 96 [33]
Yersinia pestis sc Mice Spleen 16/300 5.3 20 [34]
Citrobacter rodentium Oral Mice Colon 14/576 2.4 24 [40]
Klebsiella pneumoniae Oral Mice, cell culture Colon, intestinal cells 29/2200 1.3 48 [30]
K. pneumoniae Oral, tu Mice Colon, bladder 19/1440 1.3 48 [31]
Proteus mirabilis tu Mice Bladder 32/2088 1.5 47 [41]
Xenorhabdus nematophila Contact Nematode Intestinal vesicle 15/3000 0.5 48 [14]
Pasteurella multocida ip, im Mice, chicken Blood 15/420 3.6 42 [42]
Actinobacillus
pleuropneumoniae
it Swine Lung 105/2064 5.1 48 [43]
Haemophilus influenzae ip Rats Blood 24/1632 1.5 24 [44]
Pseudomonas aeruginosa it Rats Lung 13/1056 1.2 11 [23]
P. aeruginosa it Rats Lung 160/7968 2.0 72 [32]
Brucella melitensis ip Mice Spleen 36/1152 3.1 96 [45]
Neisseria meningitides Serum resistance 37/4548 0.8 44-48 [18]
Burkholderia pseudomallei ip Mice Spleen 1/96 1.0 96 [46]
Burkholderia cenocepacia it Rats Lung 102/2627 3.9 37 [28]
Campylobacter jejuni Oral Chicken Cecum 29/1550 1.9 74-82 [15]
Helicobacter pylori Oral Mongolian gerbils Stomach 252/960 26.3 24 [47]
Staphylococcus aureus ip Mice Spleen 24/6300 0.4 50 [26]
Streptococcus pneumoniae in Mice Lung 387/6149 6.3 63/40 [17]
Streptococcus group A
(GAS)
sc Mice Spleen 1/21 4.8 21 [25]
Mycobacterium tuberculosis iv Mice (knockout) Lung, spleen, liver 3/48 6.3 48 [29]
Mycobacterium marinum ip Goldfish Liver 40/1008 4.0 48-53 [48]
Mycobacterium bovis sc Guinea pigs Spleen 15/1215 1.2 45 [49]
a APEC, avian pathogenic E. coli; EHEC, enterohemorrhagic E. coli; S. e., Salmonella enterica; UPEC, uropathogenic E. coli.
b im, intramuscular; in, intranasal; ip, intraperitoneal; it, intratracheal; iv, intravenous; sc, subcutaneous; tu, transurethral.
c GI, gastrointestinal.mutant during the negative selection screen. An elegant
way in which to screen 72 mutants simultaneously with a
tag-pool size of 24 Lehoux-tags was shown by Potvin et al.
[32]. They used three transposons that differed only in
the incorporated selection markers. For detection, this
study employed multiplex PCR, using three selection
marker-specific primers instead of one generic primer.
However, unlike hybridization, PCR detection does not
allow different attenuation levels to be distinguished.
This limitation led Hunt et al. [28] to introduce real-time
PCR detection. Real-time PCR allows the relative quan-
tification of template DNA, in this case of the different
mutants represented in a pool [28].
Mutation site identification
To date, one of the major shortcomings of STM has been
the inability to detect whether a certain gene is dispensable
during negative selection or whether it is simply not
present in the mutant library. Only one approach, pub-www.sciencedirect.comlished by Geoffroy et al. [18], aimed to map the transposon
insertion sites of all mutants tested in their STM screen to
answer this question. Despite the knowledge of mutational
coverage, this comprehensive mapping is not a preferential
strategy owing to the high time and labor consumption.
Further characterization
The STM method can be reused for testing randomly
chosen or deliberately selected mutants in pools. Merrell
et al. [33] subjected a pool of selected Vibrio cholerae
intestinal colonization-attenuated mutants, denominated
virulence-attenuated pool (VAP), to a cell-free assay for
acid shock. In addition, further analyses can comprise
testing of mutants individually for their specific pheno-
type. Thereby, STM has the advantage that the output of
the selection are interesting mutant strains, which can be
used directly for further investigation, for example to
evaluate possible vaccination targets in the human patho-
gen Yersinia pestis [34].Current Opinion in Microbiology 2005, 8:1–8
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Table 2
Technical details of the STM studies presented in Table 1.
Speciesa Transposon Tags Detection
systemb
Mutation site
identificationc
Special featuresd Reference
S. e. Typhimurium miniTn5 Hensel-tags rh (cb) c, s First STM screen [1]
S. e. Typhimurium miniTn5 Hensel-tags rh (dbp) c, s Two negative
selection systems
[35]
S. e. Choleraesuis miniTn5 Hensel-tags rh (cb) c, s [36]
Escherichia coli (UPEC) miniTn5 Hensel-tags nrh (dbpl) Arbitrary PCR / c, s [37]
E. coli (EHEC) miniTn5 Hensel-tags rh (cb) c, s Auxotrophic exclusion [27]
E. coli (EHEC) miniTn5 Hensel-tags rh (cb) c, s [38]
E. coli (APEC) miniTn5 Hensel-tags nrh (dbp) Arbitrary PCR, s [39]
Vibrio cholerae miniTn5 Hensel-tags nrh (dbpl) c, s Virulence-attenuated
pools
[33]
Yersinia pestis miniTn5 Hensel-tags rh (dbpl) Single primer
PCR, s
Vaccine candidate
testing
[34]
Citrobacter rodentium miniTn5 Hensel-tags rh (dbpl) c, s [40]
Klebsiella pneumoniae miniTn5 Hensel-tags rh (cb) c, s Two negative
selection systems
[30]
K. pneumoniae miniTn5 Hensel-tags nrh (dbp) c, s Multi-screening STM [31]
Proteus mirabilis miniTn5 Hensel-tags nrh (dbpl) Arbitrary PCR / c, s [41]
Xenorhabdus nematophila miniTn5 Hensel-tags rh (dbpl) c, s First symbiosis STM [14]
Pasteurella multocida Tn916 Hensel-tags nrh (dbp) Inverse PCR, s [42]
Actinobacillus
pleuropneumoniae
mini Tn10 Hensel-tags rh (cb) c, s Vaccine candidate
testing
[43]
Haemophilus influenzae Tn1545 Hensel-tags rh (cb) Arbitrary PCR, s [44]
Pseudomonas aeruginosa miniTn5 Lehoux-tags PCR c, s First application of
PCR detection
[23]
P. aeruginosa miniTn5 Lehoux-tags PCR (multiplex) c, s Multiplex PCR detection [32]
Brucella melitensis miniTn5 Hensel-tags rh (dbp) Arbitrary PCR /
inverse PCR, s
Sequel to [50] [45]
Neisseria meningitidis Himar1 Hensel-tags rh (cb) Ligation-mediated
PCR, s
First cell-free screen [18]
Burkholderia pseudomallei miniTn5 Hensel-tags rh (cb) c, s [46]
Burkholderia cenocepacia pTnMod Lehoux-tags PCR (real-time) Self-cloning, s Real-time PCR
detection, auxotrophic
exclusion
[28]
Campylobacter jejuni Himar1
derivative
Hensel-tags nrh (dbp) c, s First commensal STM [15]
Helicobacter pylori TnMax5 Hensel-like
tags (20 bp)
PCR c, s [47]
Staphylococcus aureus Tn551 and
Tn917lac
Size-marker
tags
PCR (real-time) Inverse PCR, s SMIT, pre-tagging [26]
Streptococcus pneumoniae magellan2 Hensel-tags nrh (dbp) Arbitrary PCR, s Two-stage STM [17]
Streptococcus group A
(GAS)
IS256 Size-marker tags PCR Self-cloning, s PTTM [25]
Mycobacterium tuberculosis Tn5370 Hensel-tags rh (cb) Inverse PCR, s Knockout mice as
model
[29]
Mycobacterium marinum phasmid Hensel-tags rh (dbpl) c, s [48]
Mycobacterium bovis illegitimate
recombination
Hensel-tags rh (sbpl) c, s [49]
a APEC, avian pathogenic E. coli; EHEC, enterohemorrhagic E. coli; S. e., Salmonella enterica; UPEC, uropathogenic E. coli.
b cb, colony blot; dbp, dot blot with PCR product; dbpl, dot blot with plasmid DNA; hdh, high-density hybridization on chip; nrh, non-radioactive
labeling and hybridization; rh, radioactive labeling and hybridization; sbpl, Southern blot with plasmid DNA.
c c, cloning; s, sequencing.
d PTTM, polymorphic-tag-length-transposon-mutagenesis; SMIT, size marker identification technology.
Current Opinion in Microbiology 2005, 8:1–8 www.sciencedirect.com
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One decade after its first description, STM has become a
genetic method widely used for the in vivo identification
of virulence traits in pathogenic bacteria. Recent techni-
cal advances, mainly in the choice and combination of
negative selection system(s) and in the choice of detec-
tion systems, have broadened its applicability and versa-
tility. The STM method is an invaluable tool to provide a
better understanding of microbial behavior in vivo. The
use of other genome-scale techniques such as in vivo
expression technology, microarray analysis, genome ana-
lysis and mapping by in vitro transposon mutagenesis, or
transposon site hybridization complement the lessons
learned by STM.
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ABSTRACT 
 
Bartonellae are bacterial pathogens uniquely adapted to cause intraerythrocytic infection in 
their mammalian reservoir hosts. In the case of human-specific Bartonella bacilliformis and 
Bartonella quintana, the intraerythrocytic bacteremia leads to the clinical manifestations of 
Oroya fever and trench fever, respectively. Here, we adapted large-scale signature-tagged 
mutagenesis (STM) for the first time to Bartonella, allowing us to screen for pathogenicity 
factors required for infection of the mammalian reservoir host in vivo. A total of 3084 STM 
mutants of rat-specific B. tribocorum were screened in a rat infection model for these criteria. 
After two rounds of screening, 130 mutants showed severe attenuation compared to wild-type 
B. tribocorum. We mapped the transposon insertion sites of these mutants to 80 different 
genes, and categorized them according to their putative function. Besides already described 
pathogenicity factors responsible for interaction with the host, like the two type IV secretion 
systems VirB-D4 and Trw, we discovered factors previously unlinked to pathogenesis. These 
belong to diverse functional classes, like transport, gene-expression regulation, cell envelope 
integrity, or metabolism. A quarter of the identified genes are (conserved) hypothetical coding 
for novel pathogenicity factors. We have used an additional PCR-screening approach on the 
entire mutant library to test for the level of mutational saturation and to identify non-essential 
genes in a pathogenicity island encoding 18 gene products related to the process of type IV 
secretion. 
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INTRODUCTION 
 
Bartonellae are small, fastidious, pleomorphic, Gram-negative rods, which are pathogenic for 
a wide range of mammalian hosts. The genus Bartonella currently comprises 20 species that 
are highly adapted to their mammalian reservoir hosts. Of these 20 species, 8 have been 
associated with human disease (20). The three major human pathogens are the human-specific 
Bartonella bacilliformis and Bartonella quintana and the cat-specific Bartonella henselae, 
where humans appear as incidental hosts. The common theme of Bartonella infections in the 
reservoir host is the long-lasting intraerythrocytic bacteremia. The course of infection is most 
frequently asymptomatic, but can also lead to severe clinical manifestations like Oroya fever 
in the case of B. bacilliformis or trench fever in the case of B. quintana. Both in the incidental 
and the reservoir host, Bartonella interacts also with endothelial cells which in a 
immunocompromized individual can cause vasoproliferative lesions like verruga peruana in 
the case of B. bacilliformis or bacillary angiomatosis in the case of B. quintana and B. 
henselae (10). 
Recently, Schulein et al. developed an animal model for erythrocyte colonization of 
Bartonella in the reservoir host (73). After injection of rat-specific Bartonella tribocorum in 
the tail vein of rats, bacteria are rapidly cleared from the circulating blood. Plate-grown 
bartonellae obviously are not able to directly invade erythrocytes and are not detected in the 
blood on the first days of infection. Thus, they first have to interact with a yet not 
experimentally identified primary niche, where upon invasion they become competent for the 
subsequent hemotropic stage (73), a process including transcriptional reprogramming. So, 
colonization of erythrocytes and persistence therein is the endpoint of a complex series of 
bacterium-host interactions. To understand such a complex pathogenesis including interaction 
with and invasion into different host cell types, identification of involved pathogenicity 
factors of the bacteria are of prime significance. Here, pathogenicity is defined in a broad 
sense, i.e. the ability of a microorganism to breach barriers in the host and to thrive either 
hidden from or in the face of the host immune defense. Intraerythrocytic bacteremia is the 
hallmark of Bartonella infection in the reservoir host and is responsible for the disease 
symptoms, elicited by the human-pathogenic bartonellae mentioned above. So, bacteremia 
can be used as a read-out, whether mutant bacteria are still able to colonize the 
intraerythocytic niche. Thus, abacteremic mutants then by definition carry a mutation in a 
gene coning for a pathogenicity factor. Our current knowledge about these pathogenicity 
factors of Bartonella is summarized in the following paragraph. Using the B. tribocorum-rat 
 11
STM MANUSCRIPT - Introduction 
infection model, Schulein and Dehio (71) described mutants in components of the VirB-D4 
type IV secretion system (T4SS) to be abacteremic, proving these components to be the first 
bona fide pathogenicity factors in Bartonella. Seubert et al. discovered a second T4SS, the 
Trw system, and also could show its essential role as pathogenicity trait in the rat-infection 
model (74). Very recently, Riess et al. identified a surface-expressed, afimbrial adhesin of B. 
henselae designated as Bartonella adhesin A (BadA), formerly known as “type IV pilus” (3) 
to be a major pathogenicity factor (61). A family of variably expressed outer-membrane 
proteins (VompA-D) in B. quintana, orthologous to BadA, supports these findings (91). 
Further possible pathogenicity factors of Bartonella have been reviewed recently (20) 
and include (i) a yet not clearly characterized proteinaceous angiogenic factor, found in B. 
bacilliformis, B. quintana, and B. henselae, (ii) a secreted bacterial factor called deformin of 
B. bacilliformis and B. henselae, involved in the deformation of erythrocyte membranes, (iii) 
the flagella of B. bacilliformis, facilitating erythrocyte invasion, (iv) unusual 
lipopolysaccharide with low endotoxic activity of B. henselae and B. quintana, enabling the 
interaction with endotoxin-sensitive endothelial cells, (v) hemin-binding proteins (HbpA-E of 
B. quintana and HbpA-D of B. henselae), involved in iron acquisition, (vi) the surface-
exposed proteinaceous hemolysin of B. bacilliformis, responsible for hemolysis during Oroya 
fever, (vii) the inducible Bartonella autotransporter (Iba) family, specifically upregulated 
during endothelial infection by B. henselae in vitro and transiently activated during rat 
infection by B. tribocorum in vivo, (viii) the two gene products IalA and IalB of the invasion-
associated locus (ial) mediating erythrocyte invasion by B. bacilliformis in vitro, and (ix) 
multiple outer membrane proteins of B. henselae demonstrated to bind to endothelial cells in 
vitro (20). 
The sequencing of two Bartonella genomes, namely of B. quintana and B. henselae, 
published by Alsmark et al. in 2004 (1), opened the way for whole-genome approaches to 
comprehensively study pathogenicity factors in Bartonella. Cellular models can be applied to 
study aspects of the versatile bacterium-host interactions, but in vivo studies better depict the 
complex natural situation. A powerful technology for in vivo screening is signature-tagged 
mutagenesis (STM) (30), which allows simultaneous screening of pools of transposon 
mutants for loss of pathogenicity in an animal-infection model. Thus, factors identified by 
STM are essential for colonization in the tested model, a unique feature of STM compared to 
other in vivo screening techniques. The application of this technique identified many new 
pathogenicity factors in a broad spectrum of pathogenic bacteria and fungi (recently reviewed 
by Mecsas [49]). In STM, the transposon insertion mutants are individually marked with a 
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specific signature-tag, i.e. a short variable double-stranded DNA sequence. In pools of 
mutants, the presence or absence of a single mutant can be tested by detection of this tag. 
Originally, Hensel et al. used DNA hybridization as detection method (30), but more recently, 
Lehoux et al. described mutant detection by PCR as a simpler and more rapid detection 
technique (43), which could be even automated for high-throughput screening (42). Pools of 
mutants can be screened in an animal model, cell culture, or any other negative selection 
screen. The presence of an individual mutant in the pool before selection and its absence 
thereafter identifies the mutant as a non-colonizing mutant candidate. Since STM uses mutant 
pools, where different mutants influence each other, some STM screens employed a 
rescreening of the non-colonizing candidates in newly assembled pools to discriminate 
between fully attenuated mutants, which are attenuated in every pool tested, and partially 
attenuated mutants, which are present or not depending on the pool composition. Darwin and 
Miller (18) first described this two-stage STM. 
Here, we established large-scale STM for Bartonella to identify pathogenicity factors 
of B. tribocorum essential for inducing intraerythrocytic bacteremia during infection of the 
laboratory rat as the mammalian reservoir host. By screening 3084 transpositional mutants for 
an abacteremic phenotype, we discovered novel pathogenicity factor as well as factors 
previously unlinked to pathogenesis and re-discovered known pathogenicity factors, like the 
two T4SS VirB-D4 and Trw. We have used an additional PCR-screening approach on the 
entire mutant library to test for the level of mutational saturation and to identify non-essential 
genes in a pathogenicity island encoding 18 gene products related to the process of type IV 
secretion. 
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RESULTS 
 
Construction and testing of the transposon vector 
The transposon vector pHS003 contains an oriT for conjugative transfer, the Himar1 
transposon, carrying a kanamycin resistance marker, and a hyperactive transposase (Figure 1). 
This suicide vector construct was transferred into B. tribocorum via conjugation and 
transconjugants were tested for transposon insertions, leading to kanamycin-resistant colonies. 
The frequency of transposition events (transconjugants divided by B. tribocorum recipients) 
was 2.4x10-4. With specific PCR reactions on single colonies, we could amplify a part of the 
transposon, but no PCR product could be obtained with primer pairs derived from the vector 
backbone, indicating insertion of the transposon into the genome of B. tribocorum and 
contradicting a potential integration of the whole plasmid (data not shown). Southern analysis 
(Figure 2) confirmed this indication and showed that in each of the 13 randomly chosen 
mutants, the transposon inserted in a single copy in distinct sites of the chromosome, 
suggesting random transposon distribution. 
 
Construction of the STM mutant library 
A mixture of signature-tags was produced by PCR using degenerate oligonucleotide 
templates, ligated into transposon vector pHS006 (derivative of pHS003, see “Material and 
Methods”), and transformed into Escherichia coli NovaBlue. The central variable sequence of 
the tag allows the potential generation of more than 1022 different variants. Ninety-six 
ampicillin/kanamycin-resistant colonies were picked (E. coli NovaBlue pHS006tagn with n = 
001-096) and the inserted tag was sequenced. None of the plasmids contained identical tag 
sequences (data not shown). We chose, based on reproducible PCR detection results, 36 
plasmids to construct the STM mutant library, and transferred the tagged transposon vectors 
individually to B. tribocorum via conjugation. The overall frequency of transposition events 
of 36 individual conjugation assays presented as 2.3x10-4. From each conjugation assay, we 
selected 96 single kanamycin-resistant colonies. Using this procedure, we assembled an STM 
mutant library with 3456 mutants. 
 
Screening of the mutant library 
The first 16 mutant pools consisted of 19 differently tagged mutants, the remaining 80 mutant 
pools of 36 differently tagged mutants. Each mutant pool was used to inoculate two rats (= 
input pool, see also “Material and Methods”) and peripheral blood was drawn on days 7 and 
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14 postinfection. Bacteria were recovered from the blood by freeze-lysation and grown on 
plates (=output pool). To identify abacteremic mutant candidates, present in the input pool 
and missing in the output pool of both rats on both time points investigated, we compared the 
individual tag-specific PCR signals in input and output pool. Of 3184 mutants tested, 100 had 
to be excluded due to missing input pool signal. One tag (tag047) was excluded from all pools 
due to constantly weak PCR detection results. Of the remaining 3084 mutants tested, 359 
were abacteremic mutant candidates. To confirm this abacteremic phenotype, we reassembled 
the 359 strains into 18 pools of 34 mutants. For keeping the pool size constant at 34 mutants 
per pool, we tested some strains repeatedly. In this rescreen, the pools were used to inoculate 
four rats, two like in the primary screen and two competitively mixed with a pool of 5 mutants 
that showed wild-type behavior in the primary screen and all contained the same tag. This 
pool was called the tagged wild-type-like pool. Since the mutants in this pool showed wild-
type behavior in the screen and carried mainly intergenic transposon insertions (data not 
shown), we assumed that this pool should be competitive like wild-type bacteria. The rescreen 
revealed 130 abacteremic mutants of the 359 candidates, which corresponds to 4% of the 
3084 mutants tested. In total, these 130 abacteremic mutants were tested absent from the 
blood of at least 6 rats (Table 1) on two time points, where bacteremia peaks with wild-type 
B. tribocorum. All abacteremic mutants have a calculated in-pool competitive index (CI, see 
“Material and Methods”) lower than 0.00001. The in vitro growth in all abacteremic mutants 
was comparable to wild-type bacteria. 
Interestingly, 47 strains could not be detected from the competition pool, where more wild-
type like bacteria were present, but they could be recovered from the mutant pools. This 
indicates that wild-type like strains outcompeted these otherwise bacteremic strains, which 
will be called outcompeted mutants in this work. 
 
Mapping of the transposon insertion site 
We determined the insertion site of the transposon for 314 of the 359 abacteremic mutant 
candidates by direct sequencing out of the transposon into the genome of B. tribocorum. The 
remaining 45 mutants gave ambiguous sequencing results, suggesting that these mutants 
might carry multiple transposon insertions. This finding is supported by Southern analysis, 
where 20 selected mutants showed unique single bands, whereas two suspected double 
insertion mutants showed also two bands (data not shown). The 130 abacteremic mutants 
represent transposition events into 80 different open reading frames (ORFs). With the help of 
the (not yet fully assembled) genome sequence of B. tribocorum (of approx. 2.7 Mb)  
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(S. C. Schuster, P. Engel, H. L. Saenz, M. C. Stoeckli, C. Lanz, G. Raddatz, and C. Dehio, 
unpublished results) and the two published Bartonella genomes of B. quintana (1.6 Mb) and 
B. henselae (1.9 Mb) (1), we annotated the affected 80 ORFs, whose predicted products fall 
into a wide variety of functional classes (Table 1). Remarkably, various multiple hits were 
found within the trw and virB gene clusters, coding for the two T4SS known to be essential 
for rat infection (71, 74). 
 
Categorization of abacteremic mutants 
Of the 130 abacteremic mutants, displayed in Table 1, 24 strains carried transposon insertions 
in intergenic regions. This localization could affect transcriptional termination of the upstream 
gene, or more likely, disrupt the promoter or regulator region of the downstream gene, or 
disrupt an operon. Additionally, the transposon could have hit a small not yet discovered 
ORF, a sequence encoding tRNA or a small regulatory RNA. We included these intergenic 
mutants in the classification as affecting the downstream gene, if the insertion was not more 
than 500 bp upstream of a gene and nearer to the downstream gene than to the upstream gene 
and if there was no indication for a functional small ORF, tRNA gene (predicted with 
tRNAscan-SE), or a sequence coding for a small regulatory RNA. This issue would 
nevertheless need further experimental exploration. Thirteen (of thirteen analyzed) intergenic 
hits could be classified by these criteria. Besides the intergenic hits, 106 transposon insertions 
occurred within 80 ORFs. These insertions can be divided into 84 hits in 64 genes with 
predicted putative function, 14 hits in 12 conserved hypothetical genes (CH) with no 
predicted function, 2 hits in 2 phage-specific genes (not present in B. henselae or B. 
quintana), and 6 hits in 2 Bartonella-specific genes. Figure 3 shows the functional 
classification of the affected genes. Genes with products involved in adhesion and invasion or 
transport over the bacterial membranes and gene-expression regulation constituted more than 
half of the total hit genes (35 and 14 of 80, respectively), highlighting the importance of these 
processes in pathogenicity. Twelve genes with products involved in the cellular metabolism, 
like energy metabolism, amino acid or cofactor biosynthesis, and carbon metabolism were 
affected. The individual mutants are listed in Table 1 with their assigned classification, their 
putative assigned function, their orthologs in B. henselae and B. quintana (if present), and the 
number of animals, in which they were tested. 
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Insertional Analysis of the virB/D4/bep Cluster 
Figure 4 shows the genetic architecture of the virB/D4/bep cluster. Herein, the virB/D4 genes 
encode a T4SS essential in B. tribocorum in vivo (73) and in B. henselae in vitro for the 
phenotypes associated with endothelial cell infections (70, 71). Recently, Schulein et al. 
discovered the cognate effector proteins encoded by the bep cluster downstream the T4SS 
structural genes (72). Interestingly, Figure 4A reveals many transposon insertions in the T4SS 
structural genes, but only one insertion in one of the effector genes (bepD1). This imbalance 
could reflect absence of further transposon insertions in the bep cluster in the entire mutant 
library or non-essentiality of bep genes individually in the in vivo situation. To discriminate 
between these two possibilities, we established a screening method for transposon insertions 
in a selected gene on the basis of the whole mutant library. This method is based on PCR with 
a transposon-specific primer and a primer flanking the gene of interest. Using the 96 input 
pools as template, we identified input pools, in which a PCR product indicated presence of a 
transposon insertion in the gene of interest. Sequencing of the PCR product determined the 
corresponding signature-tag and, thus, the mutant and the exact insertion site of the 
transposon. With this test, we confirmed abacteremic mutants in virD4, virB10, and virB9 and 
revealed the presence of transposon insertion mutants in bepA, bepD1, bepD2, and bepF in 
the library (Figure 4B, Table 2), but no insertions in the tested genes virB8, virB11, bepB, 
bepC, and bepE. Table 2 shows that most of the bep gene mutants behaved like wild-type 
bacteria in the primary screen and were, thus, not further investigated in the rescreen. One 
puzzling result of this analysis is the observation that one mutation in bepD1 led to the 
abacteremic phenotype, whereas several other mutations in the same gene conferred a wild-
type like bacteremic phenotype. 
 
Individual animal experiments 
To prove the difference between the abacteremic and the bacteremic phenotype of the bep 
mutants and to quantify possible attenuation, competition analyses of selected bep mutants 
with wild-type bacteria were done and CI were calculated (Table 2). All the tested bep 
mutants, except the bepD1 abacteremic mutant, did not show attenuation compared to wild-
type bacteria, neither in individual nor in competitive infections. The bepD1 abacteremic 
phenotype was confirmed in all animals tested. 
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DISCUSSION 
 
STM screen results 
We tested the ability of transposon insertion mutants of Bartonella to cause intraerythrocytic 
bacteremia, the central colonization niche of Bartonella in the reservoir host, to identify 
pathogenicity factors essential for host-colonization. Our results demonstrate that STM 
effectively identifies B. tribocorum genes essential for pathogenicity in the rat-infection 
model. Additionally to genes already known to be important for pathogenicity, we have 
identified a large number of loci previously unlinked to virulence. For interpretation of the 
results, it is of major importance to keep in mind that a mutation derived by transposon 
insertion not only disrupts the respective gene, but may cause polar effects on expression of 
downstream genes in the same operon. If the operon contains functionally related genes, the 
insertion remains informative. Furthermore, STM is based on the premises that each member 
of a population of bacteria has an equal opportunity to establish an infection and that each 
organism acts independently. Reality is more complex as there also will be positive or 
negative interaction between different mutants in one pool, like extracellular complementation 
or outcompetition. In the rescreen, outcompetition behavior could be shown by coinfection 
with wild-type like competition pools, where some mutants were outcompeted, whereas they 
thrived in mutant pools with less competitional power. All these mutants could be interesting 
to investigate for a better understanding of bacterial competition factors inside the host. But 
this study concentrated only on those mutants with a major defect in establishing infection 
inside the host. Thus, we only included mutants that exhibited the abacteremic phenotype 
under all conditions tested (screen and rescreen). The affected genes can be functionally 
classified in five diverse categories: (i) cellular interaction with the host, (ii) gene-expression 
regulation, (iii) cell envelope integrity, (iv) metabolism, and (v) unknown function. The first 
category can be further divided into adhesion / invasion and transport processes. 
 
Adhesion and invasion 
The mammalian body is an environment usually hostile to invading pathogens, which have to 
face the immune system and have to compete with host cells for nutrients. The outer 
membrane is the major device of bacteria to interact with host cells, the extracellular matrix, 
or soluble factors in body fluids. Therefore, outer membrane proteins can represent important 
pathogenicity factors for bacterial pathogens and have diverse functions including adhesion, 
substrate uptake, antimicrobial resistance, and resistance to serum, drugs, or bile. This STM 
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screen identified many already described pathogenicity factors in Bartonella from this 
category, thereby validating the STM approach. 
From these factors, we isolated three mutations in an autotransporter cluster (ibaB, 
ibaC, ibaD). The promoter of ibaB was shown to be induced in B. henselae during endothelial 
infection in vitro and to be transiently active in B. tribocorum at the onset of blood-stage 
infection in vivo (75). Analysis of these autotransporters reveals that they most likely serve as 
adhesins (Anja Seubert, unpublished results). To our best knowledge, these are the first 
autotransporters to be reported in an STM study. Autotransporters generally serve as adhesins, 
extracellularly released degrading enzymes or toxins (recently reviewed by Henderson et al. 
[29]). Considering their function as secreted enzymes and toxins, extracellular 
complementation in a pool of mutants could prevent detection of autotransporters in STM 
screens. As adhesins, at least partial complementation could occur by non-mutated 
homologous members of the same locus. The screen results show that the function of the 
autotransporters of the iba family must be extracellularly uncomplementable. They may act 
synergistically as adhesins, e.g. to different structures on erythrocytes during blood stage 
infection, and thus be all needed because of the adverse conditions for bacteria in the blood 
stream (e.g. high shearing forces, innate immune responses). Alternatively, they could be 
differentially expressed in different host tissues. Further investigation is required to determine 
their exact role in pathogenicity. A further adhesin was affected in mutant 087E05 that carried 
a transposon insertion directly upstream of badA, which codes for an afimbrial adhesin of 
Bartonella related to YadA of enteropathogenic Yersinia and NadA of Neisseria meningitidis. 
This adhesin BadA in B. henselae mediates binding to extracellular matrix proteins and to 
endothelial cells in vitro, and was additionally shown to be immunodominant in B. henselae-
infected patients (61). Hypothetical genes that share partial homology with badA surround the 
badA gene. The orthologous locus in B. quintana comprises the so-called vomp genes 
(vompA-D). Their products mediate autoaggregation and also adhesion to extracellular matrix 
proteins in vitro, and the locus exhibits genomic rearrangement during the course of blood 
stream infection in vivo (91). Furthermore, we discovered one transposon insertion inside the 
ialB gene and one directly upstream of it, confirming the finding that an ialB mutant in B. 
tribocorum does not develop bacteremia in the rat-infection model (Christian Gille, 
unpublished data). The encoded inner membrane protein is involved in binding of B. 
bacilliformis to human erythrocytes in vitro (14); nevertheless, the molecular action of 
erythrocyte binding and invasion is still not elucidated. A further mutant was identified as 
surA, the first gene of a multifunctional operon that maintains its structure throughout the 
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proteobacteria. When the gene is disrupted in Salmonella typhimurium, bacteria are attenuated 
in mice (85). The same can be observed in an STM screen in Klebsiella pneumoniae during 
colonization of the gastrointestinal or urogenital tract of mice (83). SurA of E. coli is a 
periplasmic molecular chaperone that assists correct folding of outer membrane proteins (39). 
The downstream gene pdxA is required for the biosynthesis of the cofactor pyridoxal 
phosphate. Insertional mutation of surA in E. coli leads to pyridoxal phosphate-auxotrophy, 
showing the polar effect of this mutation and, thus, the operon organization (88). Further 
studies on Bartonella could provide evidence whether disturbing the regulation of stationary-
phase survival by the folding action of SurA or the cofactor auxotrophy generated the 
abacteremic phenotype. 
 
Transport 
Transport processes also contribute to the interaction with the environment and are of prime 
importance for bacteria. In pathogenic bacteria, nutritional uptake, adhesion to the substratum, 
intercellular communication and interaction, or environmental sensing all contribute to the 
bacterial ability to establish infection and to persist in their appropriate host. Two clusters of 
genes with transport function code for the two T4SS of B. tribocorum, which are essential for 
in vivo pathogenesis (71, 74). Our screen revealed eleven mutants carrying transposon 
insertions in the virB/D4 cluster (virB2, virB4, virB5, virB6, virB9, virB10, virD4) and twelve 
insertions in the trw cluster (trwE, trwF, trwJ4, trwL6, trwL7, trwM, and upstream of trwL5 
and trwL6). This firstly showed that already known pathogenicity factors of Bartonella can be 
re-identified in large number. Secondly, it indicated that more than only the already tested 
T4SS mutants (virB4, virB10, virD4; trwD, trwE) are essential for correct functioning of the 
T4SS apparatuses, though polar effects on downstream genes, due to the transposon insertion 
in an operon, would have to be excluded experimentally. T4SS serve as molecular injection 
devices directly injecting bacterial effector proteins into the host cell cytoplasm. It was shown 
in B. henselae that the effector proteins of the virB/D4 T4SS, encoded by seven bep genes 
(bepA-G), are responsible for the prominent changes induced in endothelial cells in vitro (72). 
Surprisingly, only one of these seven bep genes (bepD1) contained a mutation that led to a 
abacteremic phenotype. Type III secretion systems (T3SS) are functionally similar to T4SS. 
Interestingly, in an STM screen of Yersinia enterocolitica-systemic infection in mice, several 
genes of the T3SS machinery were shown to be essential, but YopP is the only of six 
described T3SS effectors identified essential (18), similar to the finding in Bartonella type IV 
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secretion. The phenomenon of bepD1 we investigated further with a new approach and this 
will be discussed later in this chapter.  
Iron is an essential cofactor for cell metabolism and bacteria are competing with host 
cells for this factor. Therefore, efficient iron uptake from a hostile environment is another 
vital process in pathogenic bacteria. In contrast, sequestering free iron by iron-binding 
proteins, like transferrin, lactoferrin, or ferritin, constitutes a host defense mechanism against 
invading microorganisms (recently reviewed by Schaible and Kaufmann [68]). We discovered 
ten abacteremic mutants with mutations in seven genes coding for at least three different 
systems involved in iron binding and uptake. The affected hemin-binding protein B (HbpB) 
was shown in B. quintana to belong to a family of outer membrane proteins involved in hemin 
binding (51). Bartonellae are strictly dependent on hemin for growth, which was shown for B. 
henselae (66) and for B. quintana (52). Strikingly, the most abundant Hbp in B. quintana, 
namely HbpA, could be mutated by site-directed mutagenesis without impairing growth (51). 
The difference of HbpB to all other members of the Hbp family in B. quintana is a large 510-
bp insert with tandem repeats contained in one extracellular loop (51). HbpB of B. tribocorum 
contains an even larger insert of 790 bp, but of different composition. We speculate that this 
extended extracellular loop contributes to the hemin-binding function, which cannot be 
complemented by other family members in contrast to HbpA. Typically, hemin uptake is a 
TonB-dependent process involving an ABC transporter (40). The hutABC locus encodes such 
a transporter and the hutA gene carried three, the hutC gene two transposon insertions. Also 
two genes for the TonB energizer system, tonB and exbB, were affected among the 
abacteremic mutants. This energizer system seems to be important for pathogenic bacteria in 
various environments, since it was identified in several STM screens like e.g. in a screen of 
systemic rat infection by N.  meningitidis (84), of gastrointestinal mouse colonization by 
Vibrio cholerae (50), and of pneumonal pig infection by Actinobacillus pleuropneumoniae 
(77). Additionally, two genes of unlinked iron-uptake systems, also belonging to the ABC 
transporter family, ceuD and yfeD, contained insertions. This shows that at least three 
different iron-uptake systems are active and individually essential during infection of the 
mammalian host. The question remains, whether these systems are all active at the same time 
independently or switched on and off in different niches in the host. 
One of the abacteremic mutants contained the insertion inside secB, whose gene 
product binds nonfolded proteins. Due to specific binding of SecB to SecA, it plays a crucial 
role during protein export by delivering protein precursors to the general secretory pathway 
(GSP) apparatus (58). Many pathogenicity factors, including adhesins and invasins, are 
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secreted via the GSP (81). So, the abrogation of this central secretion function could be the 
reason for its detection in this STM screen. But SecB can also act as general nonspecific 
chaperone in the cytosolic protein pool, which was shown recently for E. coli (89), and is 
involved in GSP-independent secretion of a hemophore by Serratia marcescens through an 
ABC transporter (67). There is no similarity of this ABC transporter to those found in 
Bartonella; nevertheless, SecB seems to be involved in a broad spectrum of secretion 
processes and its deletion in B. tribocorum certainly affected one of these functions. 
Amino acid uptake seems to be important for survival of several pathogens inside the 
host (41). Consistently, several amino acid transporters could be identified in the STM screen. 
Two belong to ABC transporters: the ATP-binding protein LivF (084H11), responsible for the 
uptake of leucine, isoleucine, and valine, and a CH coding for a periplasmic amino acid-
binding protein affected in mutants 045B05 and 049F11. CycA is described in E. coli as H+-
symporter responsible for the uptake of D-serine, D-alanine, and glycine (62). In α-
proteobacteria, cycA is only present in the genus Bartonella and in the closely related genus 
Brucella, but only in B. tribocorum, this gene is duplicated. Despite a high degree of identity 
(74% identical, 86% similar amino acids), cross-complementation was not possible from 
CycA2 to CycA1. A mutant in cycA2 exhibited an outcompeted phenotype, which could be 
due to weak attenuation caused by the mutation or partial complementation from CycA1 to 
CycA2. Since gene duplication may lead to new virulence factors, the elucidation of the 
individual functions of CycA1 and CycA2 will be very interesting. The pha operon (with a 
transposon insertion, upstream of its first gene phaA) mediates osmotolerance in 
Sinorhizobium meliloti by its K+-efflux activity, which is important during plant cell invasion 
(57). The operon structure is conserved in the Bartonella species, indicating a possible role of 
this transporter for adaptation to new host niches. All other found transporters belong to the 
ABC transporter family, either mediating glycerol-3-phosphate uptake (ugpA and ugpB, see 
below), or transport of presently unknown substrates (yhjE, which is affected three times 
independently, and two CH proteins affected in mutants 023C11 and 045E11). 
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Gene-expression regulation 
The ability to modulate gene expression to adapt to new environments during interaction with 
different niches is also a key factor of bacterial pathogenicity. One class of regulators 
responding to extracellular stimuli is constituted by the two-component regulatory systems 
(TCRS). They are typically composed of a sensor histidine kinase, spanning the bacterial 
cytoplasma membrane, and a cytoplasmic response regulator acting as transcription factor. In 
this screen, we discovered a TCRS with BatS as sensor kinase and BatR as response regulator. 
This BatR/BatS system is highly conserved in the α-proteobacteria. In Agrobacterium 
tumefaciens, the homologous ChvG/ChvI system is necessary for bacteria-induced tumor 
formation in plants and is a regulator of acid-inducible genes, like e.g. the VirB T4SS (46). 
The ExoS/ChvI system of S. meliloti is essential for endosymbiosis (9), and the BvrS/BvrR 
system of Brucella spp. for intracellular survival and the expression of outer membrane 
proteins (27, 80). Transcriptional profiling in B. henselae discovered the BatS/BatR system as 
the key regulator of the VirB/D4 T4SS and of several outer membrane proteins (M. Dehio, A. 
Basler, M. Quebatte, G. Raddatz, S. G. Andersson, and C. Dehio, unpublished results). These 
results all support the notion that the BatS/BatR regulatory system plays a central role in 
Bartonella pathogenesis. A second TCRS, identified in the STM screen, was the FeuQ/FeuP 
system with two transposon insertions in feuQ and none in feuP. Its ortholog in Rhizobium 
leguminosarum is required for the acquisition of iron shown by site-directed mutagenesis in 
feuQ (mutagenesis was not achievable in feuP), but the precise molecular mechanism is 
unknown (90). Interestingly, the orthologous system in Brucella suis is not important for 
survival in marcrophages, in vitro growth under iron limitation, or in vivo growth in a murine 
model (24). Since the feuP response regulator orthologs exhibit high degree of amino acid 
identity (between 69-77% for Bartonella, Brucella, and Rhizobium), the differences in the 
feuQ sensor kinase orthologs (between 41-50% amino acid identity for Bartonella, Brucella, 
and Rhizobium) may reflect differences in regulation responding to a different stimulus. A 
further indication for differences in regulation by the FeuQ/P system is the fact that 
Rhizobium and Brucella rely mainly on self-produced siderophores to scavenge iron from host 
iron-binding molecules, whereas Bartonella rather directly binds hemin of the host (see 
above). We identified eleven further regulatory genes containing transposon insertions, where 
six are associated with virulence in other pathogens (chvD [47] and ros [15] in A. tumefaciens, 
gidA in Aeromonas hydrophila [76], kpsF e.g. in E. coli K1 [12], spoT e.g. in Mycobacterium 
tuberculosis [16], and lepA in Legionella pneumophila [8]). KpsF is one of many proteins 
involved in the production of a polysaccharide capsule described for E. coli K1 and S. meliloti 
 23
STM MANUSCRIPT - Discussion 
(12, 63). KpsF functions as an accessory or regulatory component of the export translocase 
(12). Since Bartonella does not contain the genes for the biosynthesis of the capsule, the 
regulatory function of KpsF could influence different transporters. SpoT is a bifunctional 
enzyme (also called Rel, mainly in Gram-positive bacteria) responsible for the synthesis and 
degradation of the signal molecule guanosine 3’, 5’-bispyrophosphate (ppGpp). The synthesis 
of this molecule is induced under nutrient-limited conditions, which then changes transport, 
metabolism of carbohydrates, amino acids, and phospholipids, known as the stringent 
response (54). In M. tuberculosis, the SpoT homolog Rel is necessary for adaptation to 
stationary phase in long-term persistence in mice (16). Bartonella also has to adopt a non-
replicative state inside erythrocytes, when nutrients and space are limiting, which resembles 
stationary phase. It will be interesting to investigate, whether this change in behavior depends 
on the stringent response. LepA is a universal bacterial GTPase, which might regulate 
ribosome function (5). Though shown not to be essential for virulence, in L. pneumophila, 
LepA is translocated via the Icm/Dot T4SS into the cytosol of protozoa (8). Since the LepA 
protein of B. tribocorum is highly homologous to LepA of E. coli (58% identity, 75% 
similarity) and of L. pneumophila (60% identity, 77% similarity), this GTPase might be a 
T4SS substrate in Bartonella, although there was no clear indication for a possible Bartonella 
intercellular delivery domain, typical for VirB/D4 effector proteins (72). As translocated 
effector, LepA might exert its GTPase activity in target cells. This is further supported by the 
finding that LepA of B. tribocorum shares 45% identity and 65% similarity with a 
Saccharomyces cerevisiae GTPase of unknown function called GUF1 (36). This screen 
further identified four regulatory genes before not been associated with pathogenesis. HflKC 
constitute a membrane-anchored regulatory complex in E. coli, which interacts with the FtsH 
zinc-metalloprotease involved in selective degradation of membrane proteins, if they are 
uncomplexed (e.g. SecY of GSP, F0 of H+-ATPase) or unstable cytosolic regulatory proteins 
(34). Bartonella contains an orthologous hflKC locus (with hflK affected in mutant 035F08, 
and hflC with an outcompeted phenotype) and a homolog of FtsH. PrmC, formerly named 
HemK, is a warning sign to not only rely on sequence homology in gene annotation (13): 
most hemK genes are annotated as protoporphyrinogen oxidase in heme biosynthesis, whereas 
no such activity could be experimentally proven. Instead PrmC/HemK in E. coli methylates a 
glutamine residue to yield N-5-methylglutamine in translational release factors, possibly 
regulating protein translation (53). Heurgue-Hamard et al. proposed therefore the new name 
PrmC (31). The other three putative regulators, whose genes were affected by the mutants 
 24
STM MANUSCRIPT - Discussion 
065D10, 074E05, and 084C04, are CH proteins with so far no indication for a specific 
function. 
 
Cell envelope integrity 
Bacterial proteins with a function in maintaining cell envelope integrity certainly are also 
important pathogenicity factors. All of the genes with deleterious transposon insertions 
belonging to this category (pal, tolQ, ispZ, phoH, and a mutation upstream of gpsA) code for 
membrane or periplasmic proteins. Pal and TolQ belong to the Tol-Pal system, shown in E. 
coli to maintain outer membrane integrity (6). Bartonella species have this system organized 
syntenically to E. coli, indicating a functional conservation of the system. IspZ is a putative 
intracellular septation protein in some α-proteobacteria, also sharing homology to IspZ of γ-
proteobacteria (e.g. Yersinia pestis or S. marcescens), but no experiments were published on 
this protein. The genes of PhoH and GpsA are both members of the phosphate starvation-
inducible (psi) genes in E. coli (11, 35) as are also the ugp transporter genes (see above). Ugp 
transports glycerol-3-phosphate, a precursor for phospholipid biosynthesis. While for PhoH 
only bioinformatical data point in this direction (32), the importance of GpsA in phospholipid 
biosynthesis is proven experimentally (59). The major regulatory molecule tightly regulating 
this process is ppGpp (78), which is synthesized and degraded by SpoT (see above). All these 
key factors involved in phospholipid biosynthesis were affected by transposon mutation in B. 
tribocorum, firstly indicating a similar regulation circuit in Bartonella and secondly 
highlighting the importance of this process in vivo. 
 
Metabolism 
The nutritional environment of the host cell imposes a requirement for de novo biosynthesis 
of various amino acids, cofactors, and nucleotides in many pathogens. Since the requirements 
change in different niches of the host, important insights into the different nutritional 
constrictions inside the host can be gained by the analysis of auxotrophic mutants, which can 
grow on complex medium in vitro, but are not capable to survive in nutritionally deprived 
niches in the host. We distinguished here between involvement in energy metabolism, amino 
acid or cofactor biosynthesis, carbon metabolism, and DNA metabolism and modification. 
PncA is active in energy metabolism in E. coli being a nicotinamidase in the cyclical salvage 
pathway for the production of NAD from nicotinamide (55). The genes aroE, dhs, glyA, and 
proA are involved in amino acid biosynthesis in E. coli. The genes aroE and aroF (called dhs 
in A. tumefaciens) participate in chorismate biosynthesis, required for the synthesis of 
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aromatic amino acids; glyA, coding for serine hydroxymethyltransferase (SHMT, see also 
below), is a key enzyme for the biosynthesis of glycine, methionine, purines, thymidine, 
choline, and lipids, and is proven essential for symbiosis of Bradyrhizobium japonicum (64); 
proline biosynthesis depends on proA (23). In E. coli cofactor biosynthesis, cobT (upstream 
intergenic hit in 061E02) is involved in cobalamin biosynthesis, panB in pantothenate 
biosynthesis, important for the assembly of coenzyme A, ribD in riboflavin (FMN, FAD) 
biosynthesis, and ubiA in ubiquinone biosynthesis (for an overview over all the pathways, see 
[54] or www.biocyc.org). All these auxotrophies still await experimental testing of B. 
tribocorum growth on minimal medium deprived of the respective essential factor. MaeE 
catalyzes the oxidative carboxylation of malate to pyruvate, a key step in carbon metabolism. 
An enzyme with 5-formyltetrahydrofolate (formyl-THF) cyclo-ligase activity is widespread in 
bacteria and eukaryotes (normally found in mitochondria). It converts irreversibly formyl-
THF, a potent inhibitor of SHMT (see glyA above) and other enzymes of C1 metabolism, to 
5,10-methenyl-THF. This conversion not only derepresses SHMT, 5,10-methenyl-THF itself 
is a substrate for SHMT in C1 metabolism (82). The genes involved in this pathway, glyA (see 
above) and the cyclo-ligase gene (in mutant 010H04), were discovered in the STM screen, 
indicating the importance of C1 metabolism for pathogenesis. Furthermore, DNA 
modification enzymes like RecA and UvrB, active in DNA repair under stress conditions, are 
important for pathogens, because the situation in the host elicits major stress for invading 
bacteria. The importance of RecA in vivo has already been shown in Brucella abortus (86) 
and the expression of uvrB was shown in E. coli to be indirectly controlled by RecA (69). In 
Bartonella, stress conditions may include survival in macrophages (33), an acidified 
environment, in which uvrB was shown to be important for survival of M. tuberculosis (19). 
 
Unknown function 
For 19 genes discovered in this STM screen, we do not have good indications for their 
functional role in the bacterial cell. Five genes contain predicted signal peptide sequences at 
their N-terminus, indicating that their gene products are secreted. We predicted membrane 
localization for five gene products because of the presence of transmembrane helices. Of 
special interest is a membrane protein (affected in 045H05) with a GGDEF and an EAL 
domain. These two domains are described to inversely regulate the levels of cyclic di-GMP, a 
second messenger involved in the regulation of many cellular processes (reviewed by 
D’Argenio and Miller [17]). Normally, bacteria contain more than one protein containing one 
or both domains, but in Bartonella, only this one protein was found. If its enzymatic action on 
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cyclic di-GMP can be shown, it would be an ideal system to study changes in cyclic di-GMP 
levels. Two genes affected by transposon insertions (069G06, 069H03) have no homologs in 
the two fully sequenced Bartonella genomes and seem to be of phage origin. Closer analysis 
of the phage loci in B. tribocorum may clarify the role of these two proteins. Of highest 
interest is one large Bartonella-specific protein (approx. 1501 aa), whose gene contained five 
independent transposon insertions. It carries a predicted signal peptide, but beyond this, no 
homology to other proteins available to date and no obvious domain structure could be 
observed. The orthologous regions in B. henselae and B. quintana, with proteins annotated as 
surface proteins, show similarity and synteny much below the normal level. 
[The remainder of 13 mutants can only certainly be assigned to an insertion site and affected 
ORF, when the assembly is finished.] 
 
Proof of non-essentiality of individual bep genes in B. tribocorum 
To our best knowledge, no previous STM study could answer, why some presumed 
pathogenicity factors did not show up in the screen. Is it because this factor is individually not 
essential in pathogenesis, because it can be complemented in trans by co-infecting wild-type 
like bacteria, or because there is no mutant in the STM library with its gene disrupted? We 
consider this an important issue in an STM study, since it provides information about the 
quality of the library, the number of disrupted genes, and the number of disruptions per gene. 
One approach published by Geoffroy et al. could ultimately answer this question by 
identifiying the transposon insertion sites of all mutants tested in their STM screen (26), but 
this is a very time- and labor-consuming strategy. So, we established a more focused 
approach, similar to the genetic footprinting strategy described by Smith et al. (79), to answer 
the question stated above without identifying all transposon insertion sites. This PCR-based 
approach discovers transposon insertions in a selected gene scanning the whole mutant 
library. 
As an examplary region to test this strategy, we chose the virB/D4/bep cluster, because of the 
obvious imbalance of abacteremic mutants obtained by STM (see Figure 4B). They are almost 
exclusively present in the virB/D4 genes, coding for the T4SS apparatus, and almost absent in 
the bep genes, coding for the exported VirB/D4 effector proteins (72). Our PCR screen 
verified all abacteremic mutants identified by STM in virB8-virB11 and virD4. The absence 
of mutations in virB8 and virB11 could be explained by their small size, by insufficient 
coverage of the transposon library, or by a possible lethal mutant phenotype even under in 
vitro conditions. In contrast, we discovered ten mutations in four bep genes (Figure 4B, Table 
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2), which all did not show severe attenuation in the STM screen. We concluded that these bep 
genes were individually not essential for pathogenicity. To exclude that extracellular 
complementation by the bep orthologs from other mutant strains in the pool leads to mutant 
behavior like wild-type bacteria, we infected rats with single bep mutants (with or without 
competition with wild-type bacteria). These mutants grew and persisted inside the rats 
comparable to wild-type bacteria shown by CI of the mutants not differing more than ten-fold 
from wild-type bacteria (Table 2). This demonstrated that these tested bep genes were 
individually not essential in the in vivo situation or were intracellularly complementated by 
bep paralogs. Interestingly, the Bep proteins can be distinguished into three categories: BepA, 
BepB, and BepC show similar protein domain organization and reveal in B. tribocorum 40% 
identical amino acids compared to each other. Accordingly, BepD1, BepD2, BepE, and BepF 
constitute a second cluster of effector proteins, less similar in amino acid sequence, but each 
containing multiple putative tyrosine phosphorylation motifs. In B. henselae, BepD was 
shown to get tyrosine-phosphorylated upon translocation into eukaryotic target cells in vitro 
(72). The third category consists only of BepG, which is present in B. henselae, but not in B. 
tribocorum. The individual paralogs of one cluster might complement each other. The PCR 
screen could not identify mutants in some bep genes, namely bepB, bepC, and bepE, in the 
mutant library, but we do not want to make conclusive statements based on the absence of a 
PCR band; so, their contribution to pathogenicity remains to be elucidated. Only one bepD1 
mutant (of six bepD1 mutants in total) showed an abacteremic phenotype in the STM screen. 
Whether this mutation has a polar effect on the downstream bepD1D2EF cluster or whether 
the mutant protein exerts a dominant negative effect during active protein secretion, e.g. by 
blocking the transport machinery, needs further experimental scrutiny. This PCR-screening 
approach showed its suitability to analyze focally individual genes or gene clusters, enabling 
the comparison of the abacteremic mutants with chosen mutants from the whole mutant 
library used in the screen. Additionally, this approach is a fast way to retrieve a transposon 
insertion mutant in a gene of interest from the library for further testing. 
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Conclusions 
Summarizing the results of the STM screen, we conclude that a major part of the affected 
genes code for proteins involved in cellular interaction with the host or gene-expression 
regulation, where future experiments have to reveal the specific contribution to pathogenesis. 
Remarkably, almost all discovered pathogenicity factors have close homologs in the related 
α-proteobacteria, confirming earlier observations, (i) that plant- and human-pathogenic α-
proteobacteria share survival strategies and host-cell interaction schemes (2) and (ii) that 
genes required in the intracellular lifestyle of Brucella are also involved in A. tumefaciens 
virulence and Rhizobium symbiosis (44). The latter finding is reflected in the found overlap 
between this STM screen in Bartonella and those in Brucella (22). Besides these 
pathogenicity factors with a known or presumed role in pathogenesis, we also identified a 
large number of CH and hypothetical proteins, supporting the notion of Perry (56) that so far, 
we have only a very limited understanding of the many gene products found in the bacterial 
genomes sequenced to date. We anticipate that this large-scale STM analysis and future work 
based upon it will lead to a deeper understanding of the processes by which B. tribocorum 
establishes a successful infection and maintains its persistence inside the host. Comparative 
analyses with the other bartonellae will broaden this knowledge to understand the common 
features of Bartonella pathogenesis.  
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MATERIAL AND METHODS 
 
Bacterial strains and growth conditions. All bacterial strains and plasmids used in 
this study are listed in Table 3. For cloning, E. coli NovaBlue was used, and for plasmid 
mobilization to Β. tribocorum, E. coli β2155. E. coli strains were grown at 37°C overnight in 
Luria Bertani broth supplemented with 200 mg l-1 ampicillin, 50 mg l-1 kanamycin, or 1 mM 
diaminopimelic acid, where appropriate. B. tribocorum IBS 506T and its derivatives were 
grown for 2 days on Columbia agar containing 5% defibrinated sheep blood (CBA) in a 
humidified atmosphere with 5% CO2 at 35°C. For the B. tribocorum transposon mutants, 
CBA was supplemented with 50 mg l-1 kanamycin at all times (CBA-Km). For the Smr B. 
tribocorum strain RSE149, CBA was supplemented with 100 mg l-1 streptomycin at all times 
(CBA-Sm). 
 
Animal husbandry and housing. RCC Füllinsdorf, Switzerland, provided 10 weeks-
old female WISTAR rats, which were housed in an animal facility under Biosafety Level II 
conditions (2 rats per cage). All animals showed good health and did not exhibit any signs of 
disease or changed behavior before, during, and after the experiments. They could acclimate 
to the facility and the diet at least 5 days prior to infection. Food and water were provided ad 
libitum. Animal care was performed and animal well-being ensured in accordance with the 
Swiss Act on Animal Protection and Good Animal Care Practice. 
 
Transposon vector construction. To construct the transposon vector pHS006, the 
following strategy was applied: The plasmid pHS001 was derived by digesting pLRS14 with 
XbaI/BamHI followed by a Klenow fill-in reaction and self-ligation. A fragment of pTnT7PA 
containing the Himar1 transposon and the oriV was cut out of the plasmid with NdeI (4646 
bp), treated with Klenow fill-in, cut again with PciI, and ligated into pHS001, cut with NheI 
followed by Klenow fill-in and cutting with PciI, giving rise to pHS002. The gene of the 
hyperactive transposase was isolated from pBADC9 by digestion with NheI/HindIII and 
Klenow fill-in (1133 bp). This fragment was then ligated into the Ecl136II-digested pHS002, 
resulting in pHS003 (Figure 1). The plasmid pHS005 was derived from pHS003 by killing of 
a second XhoI site (partial digestion with XhoI, Klenow fill-in reaction, self-ligation), 
additional to the XhoI site in the transposon. The plasmid pHS006 was derived from pHS005 
by killing of a second AatII site (partial digestion with XhoI, Klenow exonuclease reaction, 
self-ligation), additional to the AatII site in the transposon. 
 30
STM MANUSCRIPT – Material and Methods 
 
Cloning and transposition test. Plasmid pHS003 was transferred from E. coli 
NovaBlue to E. coli β2155 by electroporation and subsequently to Β. tribocorum by 
twoparental mating (21). Thirteen single kanamycin-resistant B. tribocorum colonies were 
isolated and, firstly, tested by colony PCR for the presence of the transposon or of the whole 
vector using the primers LHS004/005 (Table 4) or LHS003/007 on the transposon or in the 
vector backbone, respectively. Secondly, southern blot analysis was done with these 13 
samples. Therefore, genomic DNA of the mutants was isolated with the QIAGEN Genomic 
DNA Isolation kit (QIAGEN, Hilden, Germany), digested with EcoRI, separated by agarose 
gel electrophorese, and blotted on a nylon membrane. The membrane was probed using a 
1216 bp XbaI/XhoI fragment of pHS003 as transposon probe and a 774 bp PstI fragment of 
pHS003 as vector backbone probe following standard protocols (65). 
 
Tag construction and insertion into the vector. A pool of degenerated single-
stranded 120-bp DNA molecules (STM oligo) containing a central stretch of 50 random bp 
([NK]50) flanked by two constant sequences was generated by oligonucleotide synthesis 
(Microsynth, Balgach, Switzerland). These constant sequences contained AatII and XhoI 
cutting sites directly flanking the random sequence. The STM oligo was amplified by PCR 
using primers LHS028 and LHS029, the resulting product recovered from a 3% agarose gel, 
digested with AatII and XhoI, and subcloned into pHS006 (also digested with AatII and XhoI). 
After introduction of tagged pHS006 into E. coli NovaBlue by electroporation, 96 single 
colonies were grown to larger quantity, plasmid DNA was extracted and sequenced with 
primer LHS018 and LHS019 to obtain the inserted tag sequence. From these sequenced 
plasmids, 59 contained a tag, were therefore chosen and denominated pHS006tagn (n stands 
for the tag number 001 to 096 according to the colony number from above). The 
corresponding E. coli strains were stored at -70°C. 
 
Transposon library construction. A total of 42 pHS006tagn vectors were separately 
introduced into E. coli β2155 by electroporation and subsequently transferred to Β. 
tribocorum by twoparental mating (21). A total of 36 vectors were chosen based on 
reproducible detection (see “Testing of tag-specific detection primers”) and used to produce 
kanamycin-resistant B. tribocorum transconjugants. From each mating, 96 single kanamycin-
resistant B. tribocorum colonies were transferred to a 96-well plate, labeled with the tag 
number for storage at -70°C. 
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For some mutants, presence of the transposon or of the whole vector was checked by PCR 
(see “Cloning and transposition test”). 
 
Testing of tag-specific detection primers. For each tag, a specific primer was 
designed (Table 4) for PCR together with a generic primer on the transposon (Srev01). Each 
primer was tested on a mix of all possible templates (as used in the input pools, see “PCR 
detection”) and on this mix without the corresponding tag as template. If a primer was not 
specific, a new one was designed for this tag and retested. All 36 tags used in this study could 
be specifically and reproducibly detected. 
 
Animal infections. Infections were done using the B. tribocorum rat-infection model 
described before (73). For infection, 36 differently tagged mutants were grown separately 
from the transposon library for each input pool, same amounts of each mutant were pooled in 
PBS directly before infection, and used to infect two rats with an inoculum of 109 bacteria 
(0.3 ml of OD595 = 1) intravenously in the tail vein. Half the remainder of these input pools 
was stored at -70°C, the other half was heat-denaturated at 100°C for 15 min and used as 
template for the detection PCR. Blood was taken from the tail vein of the infected rats after 7 
and 14 days postinfection, bacteria released from erythrocytes by freeze-lysation, serially 
diluted in PBS, and plated on CBA-Km. Grown bacterial colonies (the output pool) were 
counted, harvested in PBS, one half stored at -70°C and the other half heat-denaturated at 
100°C for 15 min. The latter part of the output pool served as template for the detection PCR. 
The rescreen was done following the same protocol with minor changes mentioned in the 
“Results”. An in-pool CI of abacteremic mutants can be estimated using the determined CFU 
of wild-type bacteria after 7 or 14 days of infection (approx. 107 CFU per ml blood) and the 
detection limit of the detection PCR (approx. 102 CFU per ml blood) for calculation. The 
input ratio between a wild-type (or wild-type like) strain and an abacteremic mutant strain 
equals 1:1, so the in-pool CI can be calculated by dividing the CFU of the abacteremic mutant 
(below detection level) by the CFU of wild-type bacteria, which results in an in-pool CI of  
<0.00001. 
 
PCR detection. For each input and output pool 36 tag-specific PCR reactions were 
done. For the PCR, the tag-specific primers (Table 4) were used together with the generic 
primer Srev01 to yield a product of approx. 600 bp. The conditions for the touchdown PCR 
were as follows: After a first denaturation step at 95°C for 5 min, 30 cycles of PCR followed. 
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The first 20 cycles consisted of denaturation at 95°C for 1 min, annealing for 30 s, that started 
with 62°C lowered in steps of 0.5°C every cycle, and extension at 72°C for 1 min. Then 10 
cycles followed, with denaturation at 95°C for 1 min, annealing at 52°C for 30 s, and 
extension at 72°C for 1 min. The program was finished by a last extension step at 72°C for 5 
min. The PCR products were displayed on a 1.7% agarose gel. 
 
Identification and analysis of transposon insertion sites. Genomic DNA from 
single mutants, regrown from the mutant library, was isolated following the QIAGEN 
Genomic DNA Isolation protocol. Diluted genomic DNA (0.5 mg ml-1) was used for 
sequencing with primers LHS001 and LHS002. The sequences obtained by the genomic 
sequencing were compared to the contigs of the B. tribocorum genome by BlastN to find the 
exact transposon insertion sites. In the surrounding of these sites, ORFs were predicted, and 
their translated amino acid sequence was compared to the nr database 
(http://www.ncbi.nlm.nih.gov/blast/html/blastcgihelp.html#protein_databases) by BlastP. For 
further analysis, the following programs or online-tools besides the ones on the NCBI-site 
were used: ClustalW (v1.82) (87) for multiple alignments, tRNAscan-SE (v1.21) (48) for 
prediction of tRNA genes, PSORTb (v2.0.3) (25) for subcellular protein localization, SMART 
(v4.0) (45) for protein domain comparisons, SignalP (v3.0) (4) for prediction of signal peptide 
sequences, the EMBOSS tools (60) for local sequence alignments or sequence modifications, 
the Biocyc database (http://www.biocyc.org, see also Krieger et al. [37]) for data searches 
about functional information of genes, coliBASE (7) and its derivative for rhizobacteria, 
RhizoDB, for ortholog searches or comparisons of synteny in γ- and α-proteobacteria, 
respectively. 
 
PCR assay for further transposon insertions. For each tested gene, two primers 
were designed (Table 4), one shortly before the start codon (start primer) and the other one 
shortly after the stop codon (stop primer). The 96 heat-denaturated input pools served as 
template for PCR. For each gene, two 96-well PCR reactions were done on this template 
using the touchdown PCR program stated above. One PCR reaction with the gene start primer 
and the transposon-specific primer LHS018, and the other reaction with the gene stop primer 
and LHS018. Each PCR product was confirmed by a single PCR reaction on the respective 
input pool and used for sequencing with primer LHS018 for the signature-tag sequence, and 
primer LHS002 for the precise insertion site of the transposon. 
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Single and competitive infections with transposon insertion mutants in bep genes. 
Single mutants were grown on CBA-Km, harvested, and used to infect two rats with an 
inoculum of 109 bacteria (0.3 ml of OD595 = 1) intravenously in the tail vein. For 
competitional infections, the same amount of a single mutant and B. tribocorum RSE149 
(grown on CBA-Sm) was mixed, adjusted to OD595 = 1, and used to infect another two rats as 
mentioned before with 0.3 ml of the adjusted bacterial suspension. Blood was taken from the 
tail vein of the infected rats after 7 and 14 days postinfection, measured by weight, bacteria 
released from erythrocytes by freeze-lysation, serially diluted in PBS, and plated on CBA-Km 
and on CBA-Sm. Grown bacterial colonies were counted and the CFU per ml blood was 
determined. CI were calculated by dividing the CFU of mutant bacteria by the CFU of wild-
type bacteria. 
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FIGURES AND TABLES 
 
 
 
Figure 1: Plasmid map of the conjugative suicide mutagenesis vector pHS003. The plasmid 
contains the Himar1 transposon, flanked by two inverted repeats (IR), the transposase (Tpase) 
under the control of the promoter Ptaclac, followed by the gfp gene, the lac repressor (lacIq), 
two antibiotic resistance markers indicated by KmR (kanamycin) and AmpR (ampicillin), the 
origin of replication (oriV) and the origin of conjugal transfer (oriT). Plasmid pHS006 is a 
derivative of pHS003 deleted for the two cutting sites marked with an asterisk. The tags were 
inserted into pHS006 between the remaining AatII and XhoI sites. For southern blot analysis, 
a XbaI/XhoI fragment containing KmR was used as transposon probe and a PstI fragment 
containing gfp.  
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Figure 2 : Southern blot of single transposon insertion mutants. For southern blot analysis, a 
1216 bp-XbaI/XhoI fragment of pHS003 (Figure 1) was used as transposon probe and a 774 
bp-PstI fragment as vector backbone probe. The lanes are numbered from 1-17: 1, undigested 
pHS003; 2, pHS003 digested with XhoI/XbaI to yield the 774 bp-transposon probe fragment; 
3, pHS003 digested with EcoRI to yield a 4156 bp-fragment; 4, B. tribocorum wild-type 
genomic DNA digested with EcoRI; 5-17, genomic DNA of 13 randomly chosen 
transpositional mutants, digested with EcoRI. Numbers on the left indicate the sizes in kbp. 
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Figure 3: Functional classification of the STM mutants. The category “Cellular Interaction 
with Host” is subdivided in the right panel. In the different classes, numbers in front of 
brackets indicate the distinct affected genes; numbers in brackets indicate the number of 
independent transposon insertion mutants. 
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Figure 4: Mapping of transposon insertions in the virB/D4/bep cluster. The screen for 
abacteremic mutant phenotypes revealed a high frequency of insertions in the structural genes 
of the T4SS (virB and virD4) and only one insertion in one of the effectors (bepD1) (A). 
Other effector genes also contained transposon insertions not leading to a abacteremic 
phenotype shown by testing the mutant library (B). The filled triangles symbolize the 
transposon insertions generating abacteremic mutants (asterisks indicate insertions confirmed 
by the insertional analysis using the PCR assay), the empty triangles those insertions 
identified by the PCR assay. 
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Table 1: Characterization of the abacteremic mutants. Gene Size is given in base pairs (bp), 
the columns BH and BQ list the homologous genes in B. henselae and B. quintana, 
respectively. The last column lists the number of animals, the mutant was tested in. CH 
denotes conserved hypothetical proteins. 
 
Gene Name Mutant Putative Function Gene Size BH BQ Animals
Cellular interaction with host    
Adhesion and invasion    
ibaB 087G03 inducible Bartonella autotransporter 2475 BH13140 BH13160 6
ibaC 035E04 inducible Bartonella autotransporter 2421 BH13160 BH13140 6
ibaD 035B11 inducible Bartonella autotransporter 1656 BH13120 BH13160 6
badAa 087E05 adhesin 15168 BH01510 BQ01400 6
ialB/invBa 079G06 invasion protein B 558 BH01650 BQ01550 6
ialB/invB 025H06 invasion protein B 558 BH01650 BQ01550 6
surAa 087D02 assembly of outer membrane proteins 966 BH05420 BQ04600 6
Type IV secretion    
trwE 041H01 channel subunit 1140 BH15750 BQ12670 6
trwE 069G08 channel subunit 1140 BH15750 BQ12670 6
trwF 025D10 ATPase energizer 825 BH15740 BQ12660 6
trwF 086D01 ATPase energizer 825 BH15740 BQ12660 6
trwJ4 069B11 pilus subunit 735 BH15670 BQ12590 6
trwL2 025E03 pilin subunit 318 BH15630 BQ12530 6
trwL5a 061H11 pilin subunit 312 BH15600 BQ12530 6
trwL6a 084H03 pilin subunit 318 BH15580 BQ12530 6
trwL6 068E08 pilin subunit 318 BH15580 BQ12530 14
trwL6 083C05 pilin subunit 318 BH15580 BQ12530 10
trwL7 065C10 pilin subunit 309 BH15640 BQ12560 6
trwM 048F08 outer membrane subunit 306 BH15650 BQ12570 6
virB2 043H04 pilin subunit 318 BH13260 BQ10530 10
virB4 005G04 ATPase energizer 2352 BH13280 BQ10550 6
virB5 086H09 pilus subunit 483 BH13290 BQ10560 6
virB6 045C04 channel subunit 975 BH13300 BQ10570 6
virB6 048C07 channel subunit 975 BH13300 BQ10570 6
virB6 083H12 channel subunit 975 BH13300 BQ10570 6
virB9 023A04 outer membrane channel subunit 864 BH13330 BQ10600 10
virB10 035D10 channel subunit 1170 BH13340 BQ10610 6
virB10 079H12 channel subunit 1170 BH13340 BQ10610 6
virD4 045D05 coupling protein 1914 BH13380 BQ10640 6
virD4 048B01 coupling protein 1914 BH13380 BQ10640 6
bepD1 041H04 virB/D4 T4SS substrate 1572 BH13410 - 14
Iron uptake    
hbpB 045C06 hemin-binding protein B 1761 BH02570 BQ02430 6
hutA 065H09 outer membrane heme receptor 2175 BH04970 BQ04160 6
hutA 068G04 outer membrane heme receptor 2175 BH04970 BQ04160 14
hutA 086B05 outer membrane heme receptor 2175 BH04970 BQ04160 6
hutC 003C03 hemin transporter permease 1077 BH04940 BQ04130 10
hutC 041F11 hemin transporter permease 1077 BH04940 BQ04130 10
tonB 085H10 energizer protein for outer membrane 
transport 
777 BH04980 BQ04170 6
exbB 049C05 biopolymer transport protein 873 BH14710 BQ11710 14
ceuD 025E09 ABC transporter, ATP-binding protein 756 - BQ10330 6
yfeD 044A11 iron transport system membrane protein 903 BH00890 BQ00820 10
Other transport function    
secB 083C01 protein translocase 474 BH01020 BQ00950 14
livF 084H11 amino acid ABC transporter, ATP-
binding protein 
792 BH08250 BQ06330 10
CH 1 045B05 amino acid ABC transporter, periplasmic 
binding protein 
759 BH06370 BQ06860 6
CH 1 049F11 amino acid ABC transporter, periplasmic 
binding protein 
759 BH06370 BQ06860 10
cycA1 025T01b D-alanine, D-serine, glycine transporter 1398 BH10880 BQ08530 6
phaAa 004F08 ds60 hypo immunodominant protein 
(B.suis) us180 phaA (potassium efflux 
transporter) 
2919 BH16460 BQ13360 6
ugpA 004E12 glycerol-3-phosphate permease ABC 
protein 
882 BH01860 BQ01750 6
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Gene Name Mutant Putative Function Gene Size BH BQ Animals
Other transport function (continued)    
ugpB 048B12 glycerol-3-phosphate-binding 
periplasmic ABC protein 
1332 BH01870 BQ01760 6
yhjE 045F01 ABC transporter, membrane spanning 
protein 
1287 BH05480 BQ04660 6
yhjE 048A01 ABC transporter, membrane spanning 
protein 
1287 BH05480 BQ04660 6
yhjE 079H06 ABC transporter, membrane spanning 
protein 
1287 BH05480 BQ04660 6
CH 023C11 ABC transporter, permease 1980 BH15460 BQ12380 10
CH 045E11 ABC transporter, permease 825 BH01900 BQ01780 6
Gene-expression regulation    
Two-component regulatory systems    
batR 005B11 response regulator 720 BH00620 BQ00560 6
batR 068D01 response regulator 720 BH00620 BQ00560 14
batR 079G05 response regulator 720 BH00620 BQ00560 6
batR 079E10 response regulator 720 BH00620 BQ00560 6
batS 025F03 sensor histidine kinase 1782 BH00610 BQ00550 10
feuQ 085F09 sensor histidine kinase 1419 BH04720 BQ03920 10
feuQ 086F05 sensor histidine kinase 1419 BH04720 BQ03920 10
CH 065D10 sigma-dependent response regulator 1410 BH01780 BQ01670 10
Other regulators    
chvD 083E10 ABC transporter, ATP-binding protein 1647 BH11380 BQ09000 14
gidA 085D11 glucose-inhibited division protein 1866 BH16680 BQ13560 10
hflK 035F08 membrane regulator of protease 1167 BH10960 BQ08610 6
kpsF 086E05 polysialic capsule regulator 1002 BH01760 BQ01650 10
kpsF 087E04 polysialic capsule regulator 1002 BH01760 BQ01650 10
lepA 061E01 GTP-binding protein 1803 BH00710 BQ00640 10
prmC 086C10 translational regulator 717 BH01960 BQ01840 10
rosAR 044H11 Ros/MucR family transcriptional 
regulator 
435 BH04610 BQ03800 6
spoT 005E10 GTP pyrophosphokinase 2241 BH05040 BQ04230 6
CH 074E05 putative regulator 1419 BH03800 BQ02810 18
CH 084C04 putative regulator (araC family) 534 BH14920 BQ11900 14
Cell envelope integrity    
pal 041H09 peptidoglycan-associated lipoprotein 588 BH14790 BQ11770 10
tolQ 065G06 energizer protein for outer membrane 
transport 
744 BH14870 BQ11850 14
gpsAa 079E08 NAD(P)H-dependent glycerol-3-
phosphate dehydrogenase 
1014 BH01260 BQ01190 6
ispZ 025D03 intracellular septation protein Z 714 BH16630 BQ13510 6
Metabolism    
Energy metabolism    
pncA 004E11 nicotinamidase 606 BH11400 BQ09020 6
pncA 010G11 nicotinamidase 606 BH11400 BQ09020 10
Amino acid biosynthesis    
aroE 049A01 shikimate 5-dehydrogenase 870 BH00030 BQ00030 6
dhs 004F11 2-dehydro-3-
deoxyphosphoheptonatealdolase 
1416 BH06440 BQ06790 6
glyA 045A07 glycine/serine hydroxymethyltransferase 1329 BH07540 BQ05390 6
proA 045E05 gamma-glutamyl phosphate reductase 1254 BH01580 BQ01480 6
proA 004D05 gamma-glutamyl phosphate reductase 1254 BH01580 BQ01480 6
Cofactor biosynthesis    
cobTa 061E02 N(1)-alpha-phosphoribosyltransferase 1005 BH08100 bad 6
panB 044G12 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
813 BH05130 BQ04320 10
ribD 083F12 riboflavin biosynthesis protein 1125 BH07560 BQ05410 10
ubiA 061F09 4-hydroxybenzoate octaprenyltransferase 480 BH07550 BQ05400 10
Carbon metabolism    
maeB 061C01 NADP-dependent malic enzyme 2298 BH01010 BQ00940 6
CH 010H04 5-formyltetrahydrofolate cyclo-ligase 609 BH14400 BQ11340 14
DNA metabolism and modification    
recA 005C02 DNA repair protein 1098 BH10230 BQ07950 6
uvrB 045A11 excinuclease 2229 BH11720 BQ09330 6
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Gene Name Mutant Putative Function Gene Size BH BQ Animals
Unknown function    
ordL 086D04 oxidoreductase 1281 BH03900 BQ02920 6
phoH 085G02 phosphate starvation induced protein 1146 BH02250 BQ02130 6
rnd 048D11 ribonuclease D 1263 BH09800 BQ07560 6
CH 2 043B07 membrane protein 1053 BH11410 BQ09030 18
CH 2 045B08 membrane protein 1053 BH11410 BQ09030 6
CH 3 044A03 signal peptide protein 507 BH00190 BQ00180 10
CH 3 087E03 signal peptide protein 507 BH00190 BQ00180 6
CH 025D02  1677 BH15980 BQ12880 6
CH 035B05  771 BH08320 BQ06260 6
CH 045B10 membrane-associated zinc 
metalloprotease 
1158 BH06270 BQ06960 6
CH 045H05 GGDEF/EAL domain membrane protein 2562 BH04460 BQ03650 6
CH 061F10 methyltransferase 942 BH00120 BQ00110 6
CH 087H02 signal peptide membrane protein 807 BH12260 BQ09640 6
CHa 035F01 miaB family protein 1224 BH00200 BQ00190 6
CHa 044B07 us730 purE us200 CH membrane protein 507/603 BH14180 BQ11210 10
CHa 048F04 us100 signal peptide membrane protein 801 BH11730 BQ03410 6
hypo 025G04  3150 BH03150 - 10
hypo 069G06 phage-related membrane protein 1743 - - 14
hypo 069H03 phage-related methyltransferase 819 - - 14
hypoa 005G07 us400 CH signal peptide protein 381 BH16390 BQ13290 6
hypoa 086G03 us3 hypo us 300 hypo 420 BH14480/90 BQ11460/80 6
Bartonella-specific genes    
NOHO03 005B02  4503 - - 10
NOHO03 023H03  4503 - - 6
NOHO03 062E05  4503 - - 22
NOHO03 079H04  4503 - - 10
NOHO03 079H10  4503 - - 10
Check, when assembly is finished    
ig08 045G03 us305 comM competence protein us40 
surface antigen 
1530/1962 BH00440/50 BQ00390/400 6
ig09 005D06 us70 orphan us300 ch 693/978 BH05300/- BQ04480/- 6
ig09 045D01 us70 orphan us300 ch 693/978 BH05300/- BQ04480/- 6
ig01 023A02   nd nd 6
ig02 035A01   nd nd 6
ig06 086H01   nd nd 6
ig12 004D01   nd nd 6
ig13 084G11   nd nd 10
ig14 045E10   nd nd 6
ig15 086D03   BH13810 BQ10930 6
ig16 060C12   nd nd 10
NOHO02 043H09   - - 14
 
a The transposon insertion site lies upstream of the denoted gene 
b This mutant is taken from a test round (T01) 
 
 47
STM MANUSCRIPT – Tables 
Table 2: Results from the insertional analysis by PCR. 
 
Gene Name Mutant CI (d14) a Screen Resultb 
virB9 023A04 n.d. am 
virB10 035D10 n.d. am 
virB10 079H12 n.d. am 
virD4 045D05 n.d. am 
virD4 048B01 n.d. am 
bepA 010F12 0.2 WT 
bepD1 024C01 n.d. WT 
bepD1 043C09 n.d. WT 
bepD1 043G02 n.d. WT 
bepD1 043H08 n.d. WT 
bepD1 041H04 0.0000001 am 
bepD1 079F11 3 WT 
bepD2 085E02 0.2 Dis 
bepF 010B11 5 WT 
bepF 044D09 n.d. WT 
bepF 049E10 n.d. WT 
 
a Competitive index (CI) was calculated as CFU of mutant recovered from blood/CFU of wild 
type recovered from blood 
b Phenopytes: am, abacteremic mutant; WT, wild-type; Dis, disappearing (present on day 7, 
absent on day 14) 
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Table 3: Bacterial strains and plasmids used in this study 
 
 Genotype and relevant phenotype Source or reference 
Strains   
B. tribocorum 
IBS 506T 
Isolate from the blood of a wild rat (CIP 105476T) (28) 
B. tribocorum 
RSE149 
Spontaneous SmR strain of IBS 506T (71) 
E. coli NovaBlue endA1 hsdR17 (rK12- mK12+) supE44thi-1 recA1 
gyrA96 relA1 lacF (proA+ proB+ lacIqZ DM15::Tn10 
Tcr  
Novagen, Madison, USA 
E. coli β2155 thrB1004 pro thi strA hsdS lacZ∆M15 (F’ lacZ∆M15 
lacIq traD36 proA+ proB+) ∆dapA::erm (ErmR) 
pir::RP4 [::kan (KmR) from SM10] 
(21) 
Plasmids   
pLRS14#10 Contains oriV, oriT, the virB4 and gfp genes under 
Ptaclac, KmR 
Schulein, unpublished 
pBADC9 Contains Himar1 tpasea (with Q131R and E137K 
mutations) under araBAD promoter 
(38) 
pTnT7P Contains Himar1 transposon (with KmR) and ApR E.J. Rubin, unpublished 
pHS001 Derivative of pLRS14#10 with deletion of virB4 gene This work 
pHS002 Derivative of pHS001 with the Himar1 transposon 
(with KmR) and ApR of pTnT7P 
This work 
pHS003 Derivative of pHS002 with the tpasea of pBADC9 
under Ptaclac 
This work 
pHS005 Derivative of pHS003 with one XhoI site removed This work 
pHS006 Derivative of pHS005 with one AatII site removed This work 
 
a tpase = transposase 
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Table 4: Primers used in this study 
 
Primers Sequence (from 5’ to 3’) Purpose 
For STM establishment  
LHS001 TGTTGTTCCAGTTTGTAATACG Sequencing out of transposon 
LHS002 TCTTCTGAGCGGGACTCTG Sequencing out of transposon 
LHS003 CCTGGGCTTTTGCTGGCC Amplification of part from vector backbone 
LHS004 GGTACCGAGGACGCGTCG Amplification of part from transposon 
LHS005 CCCCAGAGTCCCGCTCAG Amplification of part from transposon 
LHS007 GGCGTGGAGCATCTGGTCG Amplification of part from vector backbone 
LHS018 TGAAGACGAAAGGGCCTCG Check of signature-tag insertion 
LHS019 CTTGCGGCAGCGTGAAGC Check of signature-tag insertion 
LHS028 TACAAAAAAGCAGGCTGACGTC Amplification of STMoligo 
LHS029 ACAAGAAAGCTGGGTCTCGAG Amplification of STMoligo 
STMoligo GGGGACAAGTTTGTACAAAAAAGCA
GGCTGACGTC [NK]25 CTCGAGACCCA 
GCTTTCTTGTACAAAGTGGTCCCC 
Starting template for signature-tag generation 
For STM detection  
S003c CTATGTAGTGATGGCGCTTG Signature-tag specific primer 
S004 CGGCCGCCAGTGTGATGG Signature-tag specific primer 
S005 AGATATCCATCACACTGGCG Signature-tag specific primer 
S010b GCGATGGATTTCTCTGTGTG Signature-tag specific primer 
S014b CGCTGTCGTTCTTGGGATG Signature-tag specific primer 
S015b GTGGTTAGTAGGTGGCGAG Signature-tag specific primer 
S023b TTGCGTGCGGTCGCGATTG Signature-tag specific primer 
S024b ATGTGTTTCGTTTTAGTGTTCTG Signature-tag specific primer 
S025 GTCCTTTCGGTGGTTATATTG Signature-tag specific primer 
S035 AGTGCGCTTGCGTTTTTTATC Signature-tag specific primer 
S040c TGGGGGTTGGTGTTGATCG Signature-tag specific primer 
S041c CGAGCGAGGTATATGTTGAGA Signature-tag specific primer 
S043b TCTTGGGGTCGCTTGTTCTC Signature-tag specific primer 
S044 GTTCGAGCGCGCACTAAAAAT Signature-tag specific primer 
S045 TATCGAGCAAGCTAGCGAAAG Signature-tag specific primer 
S047da GGTGATCTTGATGTGGCTATC Signature-tag specific primer 
S048 TAGACGTCATTTTGTCGCTAG Signature-tag specific primer 
S049 GCAAAAACCAACGCAACCGC Signature-tag specific primer 
S060 CTGATGCGTGCTAGGTGGA Signature-tag specific primer 
S061 GTCAGGGGGGGGTGTTTAA Signature-tag specific primer 
S062 TGCGGGGGATCGAGATGTT Signature-tag specific primer 
S063 ACGTCTTTGCGCGTTTTCGA Signature-tag specific primer 
S065b TTTCGCGGTGGTTAGGGAGT Signature-tag specific primer 
S068 CTGGTTCTAGTGGTTGCTCT Signature-tag specific primer 
S069c CGATCTCGCGATATGTATTTC Signature-tag specific primer 
S070c TCGTGTTGGTGGGCTGTATC Signature-tag specific primer 
S074 CAGGGTGGTAGTGGGTTAG Signature-tag specific primer 
S075 CGTCGTTGTTGGTTGTGTCT Signature-tag specific primer 
S076b ATGTGTGTTGTCATTTTTAGGTC Signature-tag specific primer 
S079b GTCTATGTGGAGGTATATAGG Signature-tag specific primer 
S083 ACGTCCTTGGTTGTTTTCTCT Signature-tag specific primer 
S084 GAGTGGTGTGCTGGAGTGC Signature-tag specific primer 
S085 TGGGGTCTATTGTTTGAGTTG Signature-tag specific primer 
S086 CTGCGCTAGGTAGATGTTTTT Signature-tag specific primer 
S087 CGTCTTCGAGTGGTCTGTTG Signature-tag specific primer 
S088 TTATGTGGAGTTAGAGTGGGT Signature-tag specific primer 
Srev01 GGACAGGTCGGTCTTGACAA Generic transposon primer 
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Primers Sequence (from 5’ to 3’) Purpose 
For PCR checks   
p5595d CTGGATCAGATCTATATTCCG Test of virB9 (upstream primer) 
LHS059 ATCGTTAATATTTTTTTCATCCAC Test of virB9 (downstream primer) 
LHS060 GTAAAGTGAACATAGGAAACAG Test of virB10 (upstream primer) 
pRS16 CTCTCAAAAAAGTACTGATAGG Test of virB10 (downstream primer) 
LHS061 TTTTACAAGAATTCTGCGATACC Test of virB11 (upstream primer) 
pRS13 ATCATTGCTTTAAAAGAGCCT Test of virB11 (downstream primer) 
pRS83 TATTCTTATCTACGCCTTTGCAAA Test of virD4 (upstream primer) 
pRS157 CTAGTTTTTCTTTTGTGGGGC Test of virD4 (downstream primer) 
VirB16 TTGGCGGTGACTAAGACAA Test of bepA (upstream primer) 
pRS111 CAAAGGCGTAGATAAGAATAAC Test of bepA (downstream primer) 
LHS042 TTAAGGAGAGTTTATATGTTAGAG Test of bepC (upstream primer) 
LHS043 TAAAAGTTGATACGTTTTTAGCC Test of bepC (downstream primer) 
prFS03 GTGAAAAAAAGTCACCCACAAC Test of bepD1 (upstream primer) 
prFS04 TTACATGGCATAAGACATTCCT Test of bepD1 (downstream primer) 
prFS01 AAAAAACATCATCCACACCCA Test of bepD2 (upstream primer) 
prFS02 TTACATGGCATAAGCCATTCC Test of bepD2 (downstream primer) 
LHS045 AGGAAACATGCATGAAAAAAGAC Test of bepE (upstream primer) 
LHS046 GAATTACGTTTGTTTAGCTGGC Test of bepE (downstream primer) 
LHS047 GAGCTTGAAAGGAACATACATG Test of bepF (upstream primer) 
LHS048 AACGATGATGAGACTATCAGG Test of bepF (downstream primer) 
LHS049 ATTAAAAACTTGAAAGGAAATATGC Test of bepG (upstream primer) 
LHS050 AATTAAAGCTTATATGAATTTTAGAG Test of bepG (downstream primer) 
 
a Not used due to weak PCR product generation 
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CONCLUDING REMARKS 
CONCLUDING REMARKS 
 
This PhD thesis had the goal to identify pathogenicity factors of Bartonella essential for 
inducing intraerythrocytic bacteremia during infection of the mammalian reservoir host. The 
ability to invade erythrocytes of the host is the hallmark of Bartonella infection, facilitating 
the transmission from host to host by blood-feeding arthopods. In the case of human-specific 
Bartonella bacilliformis and Bartonella quintana, intraerythrocytic bacteremia leads to 
clinical manifestations of Oroya fever and trench fever, respectively.Only few other 
pathogens are also capable of invading mature erythrocytes, like the prokaryote Anaplasma 
marginale (5) or eukaryotic parasites of the phylum Apicomplexa, e.g. Plasmodium, the 
causative agent of malaria. These eukaryotes possess a complicated machinery, the so-called 
apical complex, to actively invade erythrocytes (for a recent review, see Soldati et al. [11]), 
which are not capable to phagocytose. How Bartonella reaches this intracellular niche is 
presently not understood. Additionally, bartonellae have first to gain competence for invading 
erythrocytes in a yet not experimentally proven primary niche, which, however, is considered 
to include vascular endothelial cells (3). To identify pathogenicity factors in vivo that enable 
the bacteria to colonize its different niches in the host, ultimately resulting in 
intraerythrocytical bacteremia, I adapted large-scale signature-tagged mutagenesis (STM) to 
Bartonella. STM is a powerful negative selection method allowing to identify those genes of a 
pathogen that are required for survival in an animal. In the ten years since its first description 
by David Holden and colleagues (4), 33 bacterial pathogens were investigated 54 published 
STM studies (see STM review, Table 1). These studies revealed by screening nearly 100000 
mutants over 1700 genes involved in pathogenicity. For large-scale in vivo screening, 
traditional random transposon mutagenesis (RTM) is hardly applicable, because each 
transposon mutant would have to be tested individually in at least one animal. In STM (based 
on RTM), unique DNA sequences, so-called signature-tags (ST), are introduced into the 
transposons. Transposon mutants with different STs can then be pooled, reducing 
substantially the number of animals needed for in vivo screening.  
For the application of STM in Bartonella, I established, in a first step, a RTM system for 
Bartonella, using the mariner family transposon Himar1. With this, I showed effective RTM 
in Bartonella tribocorum with a frequency of transposition events (transconjugants divided by 
B. tribocorum recipients) of 2.4x10-4. Furthermore, the transposon inserted in a single copy in 
distinct sites of the chromosome (see STM manuscript, Figure 2). After introduction of 36 
STs into the transposon, I generated a mutant library of 3456 tagged mutants (36 x 96). For 
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detection of the individual STs in the mutant pools, I established a PCR-detection strategy, 
optimizing the primers for reproducible tag amplification. Using rat-specific B. tribocorum in 
a rat-infection model (9), I screened 3084 STM mutants for an abacteremic phenotype in two 
rats in parallel after 7 and 14 days of infection, where bacteremia with wild-type 
B. tribocorum peaks. During the screen, Muriel Vayssier-Taussat (Ecole Nationale 
Vétérinaire Alfort, Maisons-Alfort, France) helped me with the animal experiments and the 
diploma student Michèle Stöckli with the PCR detection (12). The screen of 3084 ST mutants 
discovered 359 abacteremic mutant candidates, which I rescreened in newly assembled pools. 
In this rescreen, the pools were used to inoculate four rats, two like in the primary screen and 
two including wild-type competition (for details, see STM manuscript, results, “screening of 
the mutant library”). After these two rounds of screening, a total of 130 abacteremic mutants 
were shown to be absent from the blood of all infected rats (n ≥ 6). I mapped the transposon 
insertion sites on the not yet fully assembled B. tribocorum genome (see “Perspective”). 
Direct sequencing of the transposon flanking sequences on isolated genomic DNA of these 
mutants was done by Christa Lanz in the lab of Stephan Schuster (Max-Planck Institut für 
Entwicklungsbiologie, Tübingen, Germany). The transposon insertions in the 130 bacteremic 
mutants affect 80 genes, which I categorized according to their putative function (see STM 
manuscript, Figure 3). With these results, I first confirmed already known pathogenicity 
factors responsible for interaction with the host, like the two type IV secretion systems VirB-
D4 (7) and Trw (10). Second, I could also confirm in vivo essentiality of so far putative 
pathogenicity factors, like one of the hemin-binding proteins (HbpB) involved in iron-uptake 
(6) or the invasion-associated locus protein B (IalB) (2). Third, I identified factors previously 
unlinked to pathogenesis. These belong to diverse functional classes, predominantly transport 
or gene-expression regulation, but also cell envelope integrity or metabolism. And forth, I 
classified a quarter of the identified genes as (conserved) hypothetical. Based on their mutant 
phenotype in the STM screen, these genes code for novel pathogenicity factors. Of 
outstanding interest is one large gene, in which I identified five independent transposon 
insertions and which encodes a Bartonella-specific protein (approx. 1501 aa). Apart from a 
predicted signal peptide, no further obvious domain structure or homology to other proteins 
available to date indicates a possible function. Its putative surface presentation (or secretion) 
is supported by the finding that the orthologous regions in B. henselae and B. quintana code 
for proteins annotated as surface proteins. In contrast to the typically high sequence 
conservation and synteny between these three Bartonella species, the weak similarity and 
synteny in this region could reflect host-specific adaptation as it may be speculated for the 
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region of the Bartonella adhesin(s) BadA/VompA-D (see STM manuscript, discussion, 
“adhesion and invasion”). The fully assembled B. tribocorum will allow detailed comparative 
genomic analyses (see also “Perspective”) to understand the common features of Bartonella 
pathogenesis as well as host-specific differences between the Bartonella species.  
Despite the large number of pathogenicity factors identified, some presumed ones could not 
be discovered. Possible reasons are: (i) this factor is individually not essential in pathogenesis, 
(ii) this factor is additionally to its role in pathogenicity essential for in vitro survival, (iii) it 
can be complemented in trans intracellularly by paralogous proteins or extracellularly by the 
orthologous factor of co-infecting wild-type like bacteria, or (iv) the factor is not affected in 
the STM mutant library due to insufficient mutational saturation. To exclude the last point, I 
have developed a PCR-screening approach on the entire mutant library. As examplary region 
to analyze, I chose the virB/D4/bep cluster, coding for the VirB/D4 type IV secretion system 
(7) and its Bep effector proteins (in detail described in B. henselae [8]), because it showed a 
striking imbalanced distribution of abacteremic mutants (see STM manuscript, Figure 4). 
With the PCR-screening approach, I could show that this imbalance is not due to insufficient 
mutational saturation in the mutant library, by discovering mutants in bepA, bepD1, bepD2, 
and bepF. With growth of these bep mutants on complex medium and an infection experiment 
using single mutants (see STM manuscript, Table 2), I also excluded essentiality for in vitro 
survival and extracellular complementation by Bep orthologs, respectively. Whether these 
Bep proteins are individually not essential in pathogenesis or intracellularly complemented by 
paralogous proteins remains to be experimentally proven. 
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A large-scale functional genomics approach, like the STM study described here, is only the 
basis for many follow-up studies, focusing on specific issues discovered during the screen 
(see STM review, Figure 2 and Table 2, “further characterization”). We started several 
projects during the course of the STM study to gain more knowlegde about the resulting 
abacteremic mutants and to design focused experiments to elucidate their specific role in 
pathogenicity. One is the recently started collaboration with Matthias Christen in the group of 
Urs Jenal (Biozentrum, Basel, Switzerland), which focuses on a protein without a known 
function, but containing a GGDEF and an EAL domain, described to regulate the intracellular 
level of the second messenger cyclic-di-GMP (see STM manuscript, Table 1 and discussion, 
“unknown function”). Furthermore, I want to briefly introduce three major projects launched 
due to the STM study, describe my contribution to them, and sketch, how they will 
complement the STM results and garner deeper insight in the pathogenesis by Bartonella. 
These three projects comprise the B. triboocum genome sequencing project, the STM project 
using a mouse model, and the development and application of in vitro assays for 
B. tribocorum. 
 
B. tribocorum Genome Sequencing Project 
Knowing the genome sequence of the STM target organism is a prerequisite for mapping the 
site of mutation and thus the in silico characterization of the affected genomic region. 
Additionally, this enables the analysis of the ST mutants in comparison with genomic data. 
For example, the STM screen identified at least three different iron-uptake systems, active and 
individually essential during infection of the mammalian host (see STM manuscript, 
discussion, “transport”). The open questions, that the genomic sequence of B. tribocorum can 
answer, include: Which components constitute these iron-uptake systems? Are their genes 
organized in an operon structure? Does the genome contain additional iron-uptake systems? 
Does it contain conserved known iron-regulatory components, like e.g. fur (feuQ was also 
identified in the STM study)? 
We want to use the B. tribocorum genomic information to answer these kind of questions 
raised from the STM study. Additionally, we want to use comparative genomics, 
predominantly with B. henselae and B. quintana and other α-Proteobacteria, to analyze 
pathogenicity factors common for Bartonella pathogenesis. 
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For this project, we started in September 2002 a collaboration with the Genomics and Signal 
Transduction Research Group of Stephan Schuster at the Max-Planck Institut für 
Entwicklungsbiologie, Tübingen, Germany. I was responsible for all preparational work with 
B. tribocorum (passage through the rat, clonal selection, isolation of genomic DNA for library 
construction and pulse-field gel electrophoresis) and accompanied the project during all the 
phases, performed in Basel, and during several coordinative and logistic meetings. In 
Tübingen, one plasmid library with insert sizes of 2-5 kbp and three Fosmid libraries with 
insert sizes of 35-43 kbp were used to generate 23435 shotgun and 9377 Fosmid reads. The 
genome size was estimated to be 2.7 Mbp, so the sequences approx. produced a 7.7-fold 
genomic coverage and a 72-fold clone coverage. Full automatic assembly by the Phrap 
software (http://www.phrap.org/phredphrapconsed.html) (and other assembler programs) 
could not be achieved due to a high degree of repetitive sequences. Günter Raddatz was 
responsible for all bioinformatics work in Tübingen. Also, the construction of a detailed 
restriction map of one Fosmid library, done by the diploma student Michèle Stöckli, whom I 
supervised, together with Christa Lanz in Tübingen, could not solve the assembly problems. 
With the help of a bacterial artificial chromosome (BAC) library (insert sizes of approx. 120-
230 kbp), the master student Philipp Engel, whom I tutor, could assemble the genome 
correctly with extensive manual curation. Christa Lanz, Günter Raddatz, and Philipp Engel 
collaborated closely during the gap closure and polishing phase. Presently, the assembly of 
the B. tribocorum genome is finished and can be annotated, which will include a first 
automated annotation (Günter Raddatz) and the following manual annotation by our lab and 
the lab of Stephan Schuster (meanwhile at Penn State University, Pennsylvania, USA). 
 
STM in a mouse model 
In February 2003, we started a collaboration with Muriel Vayssier-Taussat (see above, 
“concluding remarks”), who intended to start an STM study using a mouse model of 
Bartonella infection. Since I had successfully established the STM technique in 
B. tribocorum, we invited her to transfer this STM approach to her mouse model. During all 
the work done here in Basel, I closely collaborated with her. First, we compared the kinetics 
of mouse infection of two different mouse-specific Bartonella species (B. birtlesii and 
B. taylori). In parallel, we confirmed, that these species could receive the mutagenesis vector 
via conjugation, and that the frequency of transopsition events was sufficient for RTM. 
Subsequently, we constructed a mutant library using B. birtlesii as target organism, because of 
its reproducible in vivo kinetics. This mutant library consists of 3456 mutants (96 mutants 
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each of 36 differently tagged transposons).We also already performed the negative selection 
screen for the first 576 B. birtlesii mutants, which Muriel Vayssier-Taussat analyzed by PCR 
detection. Preliminary data show 12 attenuated mutants, not detectable in the blood of two 
mice on day 7, 10, and 14 postinfection. Five of those mutants were also discovered in this 
STM study. Comparison of the results of both studies will indicate common pathogenicity 
traits in the genus Bartonella and host-specific features among bartonellae infecting different 
hosts. 
 
B. tribocorum in vitro assays 
One major advantage of STM is, that the genes of interest determined in the screen carry 
already a mutation. So the corresponding mutants can thus directly be used for further 
phenotypic characterization. To elucidate the specific function of a gene product, one can 
apply in vitro assays, where interaction between the pathogen and its host cell can be closely 
monitored. 
Whereas various aspects of B. henselae-endothelial cell interaction can be studied in in vitro 
cell culture assays (for an overview, see Dehio [3]), no in vitro system for B. tribocorum is 
described. Michèle Stöckli adapted an assay to study invasion behavior of B. henselae into 
cultured endothelial cells (Ea.hy 926, a fusion of human umbilical vein endothelial cells and 
lung carcinoma cells) to B. tribocorum (12). Testing selected ST mutants, she observed that 
mutants with a disrupted two-component regulatory system BatSR appear intracellularly in 
statistically significantly higher number than wild-type bacteria. This could indicate an 
antiphagocytic effect mediated by BatSR. During these experiments, I contributed to the 
choice of ST mutants, to the setup of the assays, and to the analysis of the results. 
Now, Philipp Engel and I plan to integrate (i) our knowledge of the BatRS regulon of 
B. henselae from transcriptional profiling experiments (1), (ii) the ST mutants with insertions 
in orthologs of the B. henselae BatSR regulon genes to test their phenotype in the invasion 
assay. With this approach, we want to identify the protein(s) in the regulon of the BatSR 
system that are directly responsible for the antiphagocytotic phenotype. 
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